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ABSTRACT 
Background and objectives 
Men who have sex with men (MSM) remain one of the groups with the highest HIV 
prevalence in the UK. The goal of this study is to help inform appropriate health 
policy by investigating the contribution to HIV transmission of various MSM 
subgroups and estimating the impacts of alternative HIV control measures. The future 
course of the epidemic is also projected. 
Methods 
Research questions were addressed through the use of rigorous data analysis and a 
partnership-based HIV transmission model that takes into account key MSM and HIV 
heterogeneities and intervention effects. The model was fitted and validated against 
the observed data and reported estimates of various types. Sensitivity analyses were 
conducted throughout the study to assess the effects of parameter uncertainty. 
Results 
Without additional interventions, the estimated 44,000 UK MSM living with HIV in 
2013 could increase to around 52,000 men by the end of the decade, with around 2,400 
new infections each year. The key group sustaining HIV transmission was the higher-
sexual activity MSM aged below 35 years living with undiagnosed asymptomatic 
HIV. Pre-exposure prophylaxis (PrEP) with 44% efficacy and 100% coverage would 
prevent approximately 10,000 cases (59% of total incidence) over 2014–2020. 
Simultaneously offering PrEP, expanding HIV testing, and initiating a test-and-treat 
programme in 25% of different target populations could save around 7,400 UK MSM 
from HIV. An extreme increase in unsafe sex and number of sexual partners would 
greatly reduce the incidence reduction but is unlikely to completely negate the 
prevention benefit. 
Conclusion 
Increasing HIV testing uptake should remain the core of the national HIV/AIDS 
strategy, but a combination of HIV prevention interventions are also necessary to 
enhance the overall performance of HIV control measures. Combining a program to 
expand HIV testing with other novel interventions, such as test-and-treat and PrEP, 
has a great potential to save thousands of UK MSM from HIV and become the key 
HIV prevention initiatives in the UK.  
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Chapter 1 :  Introduction  
 
Introduction 
  
In this chapter: 
The background and underlying rationales 
The primary research questions 
The scope of study 
The structure of thesis 
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1.1. Rationale and justification 
Sex between men continues to represent one of the most common routes of HIV 
transmission in the UK. A total of almost 11,000 deaths among men who have sex 
with men (MSM) caused by HIV infection has been reported [1] (Table 1-1). In 2007, 
there were an estimated 32,000 MSM living with HIV in the UK, and of these around 
a quarter were unaware of their HIV infection. Given that an estimated 420,000 MSM 
aged 15-44 were living in the UK, HIV prevalence among this group was estimated to 
be 5.3% [2]. The 2009 national HIV report confirms that MSM remain one of the 
groups with the highest HIV prevalence [3]. HIV transmission through sex between 
men is still a major public health problem in the UK. 
Recent surveillance information shows that the number of new diagnosed infected 
MSM increased between 1998 and 2005 and may have reached approximately 2,500 
cases since then. During 2007, around 11% of MSM have tested for HIV at a 
genitourinary medicine (GUM) clinic [2]. The uptake of HIV testing in GUM clinics 
has continued to rise but, still, around 35% of infected MSM left clinics without 
knowing that they are infected with HIV. Moreover, a community-based survey in 
2005 reported that only 48% of MSM were offered a HIV test during their last visit to 
a GUM clinic [4]. The average CD4 cell count at diagnosis among MSM has 
continued to increase from 334 in 1999 to 416 in 2008 [5]; however, around 43% were 
diagnosed with a CD4 cell count less than the threshold at which treatment should 
begin (350 cells/µL) and 20% were diagnosed during the late disease stage (CD4 cell 
count less than 200 cells/µL) which is associated with a significant increase in 
mortality within a year of diagnosis compared with those diagnosed earlier [3]. 
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Table 1-1: Summary of current HIV epidemic among MSM in the UK 
Indicators Number 
Incidence and prevalence   
Number of MSM aged 15-44 in 2007
a
 415,700 
HIV prevalence among MSM aged 15-44 in 2007
a
 5.3% 
HIV prevalence among London MSM aged 15-44 in 2007
a
 8.5% 
Annual HIV incidence among MSM in 2007
a
 1.8% 
Proportion of MSM who get infected from abroad in 2008
b,
* 17% 
Diagnoses and deaths  
Annual HIV diagnoses among MSM in 2008
c
 2,433 
Cumulative HIV diagnoses among MSM up to the end of June 2009
c
 45,947 
Annual AIDS diagnoses among MSM in 2008
c
 160 
Cumulative AIDS diagnoses among MSM up to the end of June 2009
c
 13,825 
Annual AIDS deaths among MSM in 2008
c
 180 
Cumulative AIDS deaths among MSM up to the end of June 2009
c
 10,990 
Number of MSM living with diagnosed HIV in 2007
a
 24,000 
Number of MSM living with undiagnosed HIV in 2007
a
 8,000 
HIV testing  
Number of MSM offered HIV test in 2007
a
 45,748 
Proportion of MSM accepting HIV test in 2007
a
 86% 
Proportion of MSM leaving GUM clinic undiagnosed in 2007
a,
** 35% 
Number of MSM accessing HIV-related care in 2007
a
 23,990 
Average CD4 cell count at diagnosis in 2008 (cells/µL)
d
 416 
Proportion of MSM diagnosed at CD4 < 200 cells/µL in 2008
b
 20% 
Proportion of MSM diagnosed at CD4 < 350 cells/µL in 2008
b
 43% 
GUM: Genitourinary medicine 
a
 Sexually transmitted infections and men who have sex with men in the UK: 2008 report [2], 
b
 HIV in 
the United Kingdom: 2009 report [3], 
c
 Men who have sex with men: United Kingdom HIV new 
diagnoses to end of June 2009 [1], 
d
 New HIV diagnoses show burden continuing in gay men [5], * 
calculated by dividing the number of HIV-infected MSM diagnosed in 2008 who get infected from 
abroad (=480) by the total number of HIV-infected MSM diagnosed in 2008 (=2,760), ** calculated by 
dividing the number of MSM who left the clinic undiagnosed in 2007 (=121) by the total number of 
MSM who were unaware of their infection before visiting the clinic in 2007 (=349). 
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An increase in unprotected anal intercourse (UAI) was also reported in the 2005 
sexual health survey of MSM attending community venues in London with 
approximately 25% reported UAI with partners of unknown or discordant HIV status 
[4] which presented a risk of both HIV transmission to an uninfected individual and 
cross-infection by drug-resistant strains for HIV-positive men [6]. Results from this 
survey also showed that HIV-positive men, particularly those who were unaware of 
their infection, were more likely to practice UAI, have casual partners, and have 
serodiscordant partnerships. These data and findings highlight the importance of 
evaluating and improving the HIV control interventions which is in line the 
recommendations made recently by Public Health England [2,3]. 
A transmission model that is parameterised using the latest biological, behavioural and 
surveillance data collected in the UK can be used to explore a range of interventions in 
terms of their prevention effectiveness to inform best practice. Such a model needs to 
be flexible enough to include the important biological and behavioural factors and the 
HIV testing patterns. This has the additional benefit of allowing an investigation into 
the effects of promoting different testing policies as well as policies aimed to change 
sexual behaviours. Conventional compartmental models have traditionally been 
employed to evaluate the effects of such interventions, and yet this type of model does 
not fully allow important heterogeneities (e.g. partnership duration, partnership 
concurrency) to be incorporated and, more importantly, provides a very simplistic 
representation of the role of partnerships and contact network in disease evolution. 
Moreover, there may be more than one factor that is driving the ongoing transmission 
among MSM. The contribution of these factors to net infections cannot be inferred 
easily from behavioural surveys and surveillance data because of their complex 
interactions and unknown underlying mechanism of HIV transmission. Using 
mathematical models that are informed by rigorous data analysis to gain a clear picture 
of the actual epidemic situation is, thus, necessary. 
The main objective of this study is, therefore, to develop alternative modelling 
approaches that include important heterogeneities and make a better use of available 
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data than has been attempted to date to evaluate a wide range of the current and 
potential future interventions for the control of HIV transmission in UK MSM. This 
should help inform appropriate HIV/AIDS policy and contribute towards an ultimate 
goal of providing information that leads to reduced HIV transmission among MSM in 
the UK. 
1.2. Primary research questions 
Through the use of the mathematical model, this study aims to answer the following 
questions: 
1. What are the current levels of HIV incidence and prevalence among MSM in 
the UK? 
2. What proportion of the current HIV incidence among UK MSM is contributed 
to by the following MSM sub-groups? 
a. HIV-undiagnosed MSM, diagnosed MSM who are not on antiretroviral 
therapy (ART), diagnosed MSM who are on ART 
b. MSM by HIV infection stage (primary, asymptomatic, and 
symptomatic stages) 
c. MSM by age group and sexual activity level 
3. What will be the potential future impact of implementing the following 
interventions to control HIV transmission among MSM in the UK? 
a. Changing the current HIV testing strategy, e.g. testing more frequently 
b. Changing the current ART strategy, e.g. treating infected MSM earlier 
in their disease 
c. Implementing behavioural change intervention to reduce number of 
partners and unsafe sex 
d. Introducing pre-exposure prophylaxis 
4. What is likely to be the most effective combination of feasible interventions to 
reduce HIV transmission among MSM in the UK? 
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1.3. Scope of the study 
The scope of this study is described in Table 1-2. 
Table 1-2: Summary of scope of the study 
Index Description 
Population Men who have sex with men aged 15 to 64 excluding 
those at risk of infection from sharing injection 
equipment. Men who have sex with both men and 
women are included but the transmission route will 
be limited only to sex between men. 
Disease HIV/AIDS. Effects of other sexually transmitted 
infections (STIs) are not included. 
Geographic area The entirety of the United Kingdom without 
geographic categorisation 
Epidemic timeframe Year 2000-2020 
Economic evaluation There is no economic evaluation of HIV prevention 
interventions.  
1.4. Ethical approval 
Only frequency, proportion and count data will be used in this study. There is no 
linked or traceable personal information of any kind involved, and thus, no ethical 
approval was required. 
1.5. Thesis overview 
The thesis is comprised of seven chapters. The flow diagram in Figure 1-1 describes 
the processes undertaken in this study. 
Chapter 2 reviews the mathematical modelling methodology, the development and use 
of modelling to simulate HIV transmission among MSM, and the HIV control strategy 
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suggested by modelling studies. The review also identifies important heterogeneities 
that have been used for designing the model in Chapter 3. 
Chapter 3 presents the design of the HIV transmission model and the detailed 
description of model development based on the literature review from Chapter 2. The 
resulting model illustrates the proposed input parameters that are estimated in the next 
chapter. 
Chapter 4 initiates the process of parameter estimation by exploring model parameters 
and various aspects of the required data from multiple sources in details including 
characteristics, completeness, and bias. The parameter values obtained from data 
analysis are used in the model, which then fitted to observed data in Chapter 5. 
Chapter 5 describes the fitting of the developed model. The reported HIV surveillance 
data and estimates are used to estimate unknown parameters. The final model with 
complete parameter values are then used to investigate the current HIV epidemic 
among MSM in the UK and project its future course. The primary research questions 1 
and 2 are answered in this chapter. 
Chapter 6 assesses the potential impact of a range of interventions in preventing HIV 
transmission UK MSM. The primary research questions 3 and 4 are addressed in this 
chapter. 
Chapter 7 summarises the main findings from this study as well as the limitations and 
implications for HIV prevention among MSM in the UK. 
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Model test and revision
Model fitting and validation
Literature review
Mathematical modelling
Thesis chapter 2
Thesis chapter 3
Thesis chapter 4
Prediction of impacts of
HIV interventions
Sensitivity analysis
Results on impacts of 
interventions 
Thesis chapter 6
(Research questions 3 and 4)
Overview of HIV and 
MSM characteristics
Model development
Method selection based on 
literature review
Selected method: 
Partnership-based model
Sensitivity analysis
Results on the current HIV 
Epidemic in UK MSM
Parameter estimation
Data analysis
Thesis chapter 5
(Research questions 1 and 2)
Required data
Epidemic prediction and 
model analysis
Required data
(not used in parameter 
estimation)
 
Figure 1-1: Flow process diagram of the study 
  
 
 
Chapter 2 :  Literature review 
 
Literature review 
 
In this chapter: 
The review of modelling methodology for HIV transmission 
Modelling approach evaluation and selection 
 
 
Publication: 
‗Mathematical models for the study of HIV spread and control 
amongst men who have sex with men‘ 
European Journal of Epidemiology (2011)
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2.1. Introduction 
The introductory chapter presented the motivation for this PhD and outlined the use of 
HIV transmission model to address key research questions. This chapter reviews 
relevant aspects of HIV/AIDS and men who have sex with men (MSM) characteristics 
that are important for designing HIV transmission model. The previous modelling 
works for HIV transmission in MSM since the early epidemic are also reviewed to 
help inform appropriate modelling sequences and important population 
heterogeneities.  
2.2. HIV/AIDS 
Human immunodeficiency virus (HIV) is a retrovirus that primarily infects CD4 cells 
and subsequently leads to the failure of human immune system and the acquired 
immunodeficiency syndrome (AIDS) in the late stage of infection [7]. HIV was first 
discovered in 1983 and variously named including ―lymphadenopathy-associated virus 
(LAV)‖ [8] and ―HTLV-III‖ [9] before all were found to be the same type of virus and 
renamed HIV in 1986 [7]. The first recognised AIDS cases were reported in 1981 [10] 
before AIDS was initially defined by the US Centers for Disease Control and 
Prevention in 1982 as ―a disease, at least moderately predictive of a defect in cell-
mediated immunity, occurring in a person with no known cause for diminished 
resistance to that disease. Such diseases include Kaposi's sarcoma, Pneumocystis 
carinii pneumonia, and serious opportunistic infections [11]. The new AIDS-defining 
clinical symptoms and conditions were subsequently added due to updated evidence 
on epidemiology of HIV/AIDS. The current definition of an AIDS case could vary 
across regions but commonly based either on a very low CD4 cell counts within HIV-
positive individuals, usually less than 200 cells/µL, or one or more symptomatic 
conditions that occur during the infection [12,13]. In most European countries 
including the UK, an AIDS case was defined according to the 1993 European AIDS 
Surveillance Case Definition which has not included CD4 counts in the definition 
[14]. 
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HIV is transmitted mainly through exchange of body fluids during sexual intercourse 
which has accounted for with the majority of global HIV infections since the start of 
the epidemic [15]. HIV transmission through an exposure to contaminated blood or 
blood products, and from an HIV-positive mother to child during pregnancy are also 
among the main routes. A few days after HIV enters the body and successfully bonds 
to CD4 cells, the virus replicates rapidly and causes great damage to the host immune 
system, which results in a very high viral load in the bloodstream  [16]. The host body 
then starts to seroconvert and recover CD4 cells in an attempt to fight the virus, 
whereas the viral load continues to decrease until the setpoint is reached. The viral 
load remains relatively stable at this level accompanied with a gradual decline in CD4 
cell counts for a period of approximately 8-10 years depending partly on the viral load 
setpoint [17]. No HIV-related symptoms are observed during this so-called 
asymptomatic HIV infection. The HIV-infected persons subsequently progress to the 
symptomatic stage of HIV infection where one or more opportunistic infections can 
initially be observed. Without appropriate and urgent treatment, the disease will 
progress rapidly towards AIDS with a greater frequency and severity of opportunistic 
infections that eventually leads to death [18,19]. In the absence of treatment, the 
median time from HIV seroconversion to AIDS and death is, respectively, around 10 
and 11 years in developed countries [20], and 9 and 10 years in Africa [21]. 
Two major types of HIV, HIV type 1 (HIV-1) and HIV type 2 (HIV-2), have been 
identified. HIV-1 is related to viruses isolated from the chimpanzee [22], and 
responsible for the vast majority of global HIV pandemic [15]. HIV-2 is related to 
viruses isolated from the sooty mangabey [22], and spreads mainly in West Africa but 
an increasing number of cases have been found in other parts of the world [23,24]. The 
severity of HIV-1 infection exceeds that of HIV-2 in many aspects. A direct 
comparison study suggested that HIV-1 patients have significant lower median CD4 
cell count at AIDS diagnosis and shorter survival time after AIDS than HIV-2 patients 
[25]. The excess mortality rate and mother-to-child transmission rate are also higher in 
HIV-1-infected individuals [23]. Since HIV-1 is the predominant HIV type in the UK, 
the instances of ‗HIV‘ refer to HIV-1 unless otherwise stated. 
Narat Punyacharoensin  Chapter 2: Literature Review 
12 
 
2.3. HIV and men who have sex with men 
The term ‗men who have sex with men‘, abbreviated ‗MSM‘, is defined according to 
the UNAIDS Action Framework as males who have sex with other males, regardless 
of whether or not they have sex with women or have a personal or social identity 
associated with that behaviour, such as being ‗gay‘ or ‗bisexual‘ [26]. MSM did not 
always identify themselves as gay [27]. Therefore, using the term ‗MSM‘ to clearly 
distinguish between the self-defined gender identity and actual sexual behaviours of 
persons is of high importance for the epidemiological study of the spread of HIV and 
other sexually transmitted diseases. 
MSM are at increased risk of HIV infection mainly because of the unprotected 
receptive anal intercourse (URAI) that is common among this population. A thin layer 
of mucous membrane lining the anus and rectum has a physically delicate structure, 
and contains several types of living cells including CD4 that are the main targets for 
HIV [28,29]. Irritating the rectum by an act of URAI can cause damage to the lining 
tissues and allows HIV from ejaculatory fluid to enter the body and infects the 
surrounding cells [28]. Even without ejaculating, HIV found in the pre-ejaculatory 
fluid of HIV-positive men still poses a risk for HIV infection [30,31]. The long length 
of the rectum and colon also facilitates HIV infection from URAI [32]. HIV can be 
transmitted through the unprotected insertive anal intercourse (UIAI) as well, but at a 
much lower rate than the URAI [33]. 
The 2013 UNAIDS report estimated that 7-19% of MSM are infected with HIV 
worldwide, depending on the region [15]. In many developed countries, the HIV 
epidemic among MSM is not declining despite the fact that antiretroviral treatment 
(ART) has been widely used in these countries [34]. In the UK, MSM account for an 
increasingly large proportion of new HIV diagnoses, from around 30% in 2002 to 
almost 50% in 2011 [35]. 
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2.4. HIV transmission model 
In order to model the dynamics of the HIV epidemic, two main approaches have been 
used. First, epidemic forecasts have been derived through two statistical methods: 
extrapolation and backcalculation. The extrapolation is based on fitting a statistical 
model to the AIDS incidence observed up to a particular time and using the fitted 
model to predict future AIDS incidence. The backcalculation method combines the 
knowledge about incubation period distribution and the observed AIDS incidence data 
to reconstruct the HIV incidence curve in the past and forecast the AIDS incidence in 
the near future. A common limitation of statistical models is that the mechanism of 
disease transmission and dynamics of the epidemic is ignored [36-39]. Epidemic 
projections without taking into account changes over time in the number of infected 
individuals can be misleading [40]. Moreover, the temporal effects of behaviour 
change and interventions cannot be directly incorporated, making an evaluation of 
HIV/AIDS strategies not feasible through this approach [41]. 
Another approach is through transmission (or mechanistic) models which have been 
developed to explicitly model the forces driving the epidemic. The most common 
mathematical model is referred to as the dynamic compartmental model in which 
populations are divided into subgroups (compartments) often by the disease-related 
status. Transitions between compartments are governed by model parameters that 
describe the disease evolution. Since HIV infection is incurable, the model consists of 
at least susceptible and HIV-infected compartments. The dynamics of each 
compartment can be described by the following differential equation systems. 
      
( ) ( )
( )
dS t I t
c S t
dt N
         (1) 
      
( ) ( )
( )
dI t I t
c S t
dt N
 ,       (2) 
where S(t) and I(t) denote, respectively, the number of susceptible and HIV-infected 
individuals at time t. The negative sign represents flows out of the susceptible into the 
infected compartments which is determined by the effective contact rate [42], c, the 
transmission probability, β, and the prevalence of HIV infection at time t, ( )I t
N
. This is 
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the simplest form of the HIV dynamic system in which all individuals are considered 
to be identical (except HIV status), mix randomly, and population demographics 
(birth, death, and migration) are ignored. Far more sophisticated models have been 
developed by taking into account a number of heterogeneities resulting in models that 
are able to provide broader outcomes in a more precise way. These benefits are 
highlighted in the published review presented in this chapter [43]. 
Taking into consideration the primary research questions, dynamic compartmental 
model has a strong potential to fulfil the needs of this study. The flexibility of the 
model allows various research questions to be investigated in detail. A complex 
interaction among model parameters can be explicitly studied to facilitate the 
discovery of the actual problem causes. Therefore, the literature review is focused on 
dynamic compartmental modelling of HIV transmission and control among MSM. 
2.4.1. Modelling approach 
In this section, the disadvantages of the conventional approaches are described, 
followed by a review and discussion of the alternative methods including their 
strengths and weaknesses. The main purpose is to select the appropriate approach for 
modelling HIV transmission and control among MSM. 
2.4.1.1. Disadvantages of the conventional approach 
The conventional compartmental approach (also called a ‗mean-field‘ model), in 
general, has two main drawbacks that make it far from being realistic. First, there is 
almost no limit to which a disease can spread into the population because an infected 
individual in the system will always influence, to some extent, an infection in the 
entire susceptible population. In the real-world situation, STIs are clearly limited by 
how individuals form their sexual partnership with the others and it is not possible that 
one infected individual can form partnerships with and pose an infection risk to every 
person in a large community. Even within the non-random mixing compartmental 
models where individuals from different classes mix according to some specific 
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characteristics (e.g. sexual activity, age), this unrealistic phenomenon still exists 
although it does not equally affect all individuals due to the mixing pattern. Another 
drawback is that, in the conventional approach, sexual partnerships are formed and 
separated instantaneously which, again, does not represent the actual partnership 
formation and break-up. The following two dynamic modelling approaches—the 
partnership-based model and the pairwise approximation model—are therefore 
proposed to address these limitations. 
2.4.1.2. Overview of the partnership-based approach 
In the partnership-based model, the common assumption of instantaneous interactions 
between members of a population is replaced by the sexual partnerships that last for 
some specific length of time depending on partnership formation and dissolution 
parameters. Time spent between partnerships is also explicitly taken into account. 
Sexually transmitted infections can be transmitted only between individuals within a 
partnership. For HIV transmission, the partnership-based approach was first 
introduced in 1988 by Dietz [44] with its primary aim of capturing changes over time 
in the number of single individuals (those without a partner) and the number of paired 
individuals (those with a partner). Following the notations used by Eames [45], the 
simplest form of the HIV transmission among MSM according to the partnership-
based model can be described by the following differential equation system: 
( )SI SS
dS
S P P
dt
           (3) 
( )SI II
dI
I P P
dt
            (4) 
2
SS
SS
dP S
P
dt S I
   

       (5) 
SI
SI SI
dP SI
P P
dt S I
     

     (6) 
2
2II SI II
dP I
P P
dt S I
    

,     (7) 
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where α is the partnership formation rate, ρ the partnership separation rate, and τ the 
transmission rate within partnership. The numbers of single susceptibles and infecteds 
are denoted by S and I while PSS, PSI, and PII are the numbers of paired individuals of 
different types. A formation of a partnership between two susceptibles or two infected 
respectively increases the number of PSS and PII by two. PSI and PIS have the same 
values and thus the (fixed) population size, 2SS SI IIN S I P P P     . The schematic 
diagram in Figure 2-1 illustrates changes over time in the partnership status. 
 
 
Figure 2-1: Example of transitions of partnership formation and separation 
2.4.1.3. Disadvantages of the partnership-based approach 
Although partnership duration is explicitly taken into account in the partnership-based 
model, all partnerships are assumed to be serially monogamous and overlapping 
partnerships are generally ignored. One way to address this limitation is to model 
concurrent partnerships as several rapidly changing monogamous interactions, each of 
which lasts for only a short period. Another way is to use a combination of the 
partnership-based and the mean-field models. The former is aimed to model HIV 
transmission within steady partnerships whereas the latter accounts for infection from 
concurrent partners. 
Before the partnership-based model can be used as a predictive tool for the HIV 
epidemic in UK MSM, a number of important heterogeneities must first be 
incorporated. Two HIV MSM modelling studies included simultaneously the effects of 
I
I
I
S
S
S
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S
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variable infectiousness due to disease stages, partnership concurrency, partner types, 
risky behaviour changes, HIV testing, and ART use at different disease stages [46,47]. 
Sexual activity levels and sexual roles were included in another study [48]. A 
partnership-based model with age structure has not been implemented. 
2.4.1.4. Overview of the pairwise approximation model 
The pairwise approximation model is the network-based transmission model that 
approximates the full set of partnerships between individuals in the sexual contact 
network by examining only the connections among nearby individuals [49]. The 
model allows the spread of infection in the network to be predicted and the control 
measures that strongly depend on the formation of partnership, such as contact tracing, 
to be properly investigated. In comparison with the results from the full network 
simulations, the pairwise approximation provides highly accurate estimates under the 
situation in which there is a small amount of clustering (partnerships are formed 
mainly with nearby individuals). Therefore, the method is expected to perform well for 
epidemics in large populations where majority of sexual contacts are formed 
randomly. Within highly clustered networks, this approach slightly overestimates the 
level of infection [50]. 
The formulations of the pairwise approximation model is described by following the 
notations used in a previous study by Eames and Keeling [50] with some 
modifications. Considering the basic HIV transmission model the susceptible 
individual becomes HIV infected through an infectious partner and progresses through 
the disease until being removed from the system. Using the notations given in Table 2-
1, the dynamics of the number of susceptibles and infecteds can be explained by 
   [ ] [ ]n n m
m
d
S S I
dt
              (8) 
   [ ] [ ] [ ]n n m n
m
d
I S I I
dt
            (9) 
  [ ] ([ ] [ ]) [ ] [ ]n m n m p p n m n m n m
p
d
S I S S I I S I S I S I
dt
              (10) 
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  [ ] ([ ] [ ])n m n m p p n m
p
d
S S S S I I S S
dt
   .            (11) 
Table 2-1: Notations used for model formulation 
Term Meaning 
[S
n
] Number of susceptible individuals with n partners 
[I
n
] Number of infected individuals with n partners 
[S
n
I
m
] Number of partnerships between an S
n
 and I
m
 
[S
n
S
m
I
p
] Number of triples with S
m
 having both S
n
 and I
p
 as partners 
τ Infection rate between a pair of partners 
𝜇 Disease-induced mortality rate 
[ ]n m
m
S I  
Total number of infected partners of all S
n
 
[ ]m n
n
I S  
Total number of susceptible partners of all I
m
 
[ ]n m
n m
S I   
Total number of partnerships between susceptible and 
infected individuals 
[nm] Number of partnerships between individuals with n and m 
partners regardless of their infection status 
[n] Number of individuals with n partners 
 
Changes in the number of [S
n
I
m
] over time occur as a result of four events 
corresponding to four terms in Equation (10). First, the transformation from [S
n
S
m
I
p
] 
into [S
n
I
m
I
p
] occurs at rate τ as an Sm gets infected from an Ip (Figure 2-2) and increases 
the number of [S
n
I
m
]. The same pattern is also applied to the second term which 
represents the transformation from [I
p
S
n
I
m
] into [I
p
I
n
I
m
] which decreases the number of 
[S
n
I
m
]. Next, the infection within a pair converts [S
n
I
m
] into [I
n
I
m
], and hence reduces 
the number of [S
n
I
m
]. Finally, the pair of [S
n
I
m
] is terminated because an infected 
individual is removed at rate μ by disease-induced mortality. The first terms in 
Equation (10) and (11) are identical corresponding to a transition between the two 
equations. The last term of Equation (11) which represents the transformation from 
[I
p
S
n
S
m
] into [I
p
I
n
S
m
] at rate τ will be accounted for when evaluating [ ]m nd
dt
S I . 
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Figure 2-2: Transformation of pair as a result of infection 
Since the number of new infections is proportional to the total number of [ ]
n m
m
S I  
as perceived from Equation (9), the number of pairs and triples in the system can be 
approximated by using the moment closure approximation method as follows. 
  
[ ] [ ][ ] [ ]
[ ]
[ ] [ ] [ ]
pn m m n
pn m m n
n m
n m
nm p IS I I S
S I
S I n n m m

 
 
     
       (12) 
( 1) [ ] [ ]
[ ]
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n m m p
n m p
m
m S S S I
S S I
m S
  


.             (13) 
The size of the equation set depends on the maximum number of partnerships and is 
much smaller than the equivalent full pairwise network model, making the pairwise 
approximation model much more manageable. Approximating the number of pairs 
using Equation (12) and triples using Equation (13) requires only the mixing matrices 
identical to those used in the conventional approach, making a better use of regularly 
available data [49]. 
 
 
2.4.1.5. Disadvantages of the  pairwise approximation approach 
The main limitation of the pairwise approximation model used to date is that the 
network structure remains constant over time as well as the sexual activity level [49]. 
For STIs with a very long incubation period such as HIV/AIDS, this issue is of 
I
p
I
p
τ
S
n
S
m
S
n
I
m
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particular importance. To cope with the problem, using a similar solution to the 
partnership-based model with additional mean-field compartments may be possible in 
which the static networks and partnerships with high turnover are modelled by the 
pairwise approximation model and the mean-field model, respectively. Another 
possible solution is to use the pairwise approximation model only for the recent past 
while the earlier periods are modelled by a mean-field approach. Adjustments will be 
required to properly merge together two sets of forecasts from the two different 
approaches. This issue is, however, still a challenge and will be investigated in this 
study as illustrated in the next sections. Another challenge is the possibility of 
including into the model a number of heterogeneities which have been confirmed to 
have marked effects on the epidemic projections. The inclusion must be made and 
tested before the model can be used to make quantitative predictions. 
2.4.2. Method selection 
The partnership-based model has been selected for further development in this PhD 
because it provides a more realistic approach to modelling HIV transmission. The 
partnership duration and time spent between partnerships can be explicitly taken into 
account which will result in more accurate epidemic estimates and evaluation of 
interventions. Change over time in partnership formation and break-up can be taken 
into account in the partnership-based model while in the pairwise approximation 
model, partnership between individuals is always fixed. Moreover, because of its 
relatively simple structure in comparison with the pairwise approximation model, the 
partnership-based model has more potential to be successfully integrated with a large 
number of heterogeneities among UK MSM populations. 
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2.5. Publication 
A review on modelling HIV transmission and control among MSM populations 
entitled ‗Mathematical models for the study of HIV spread and control amongst men 
who have sex with men‘ has been published in the European Journal of Epidemiology 
in September 2011 [43]. The main aims of this review were to gain an understanding 
of how models have been developed and used to explain the dynamics of the HIV 
MSM epidemic with and without control measures. The MEDLINE and EMBASE 
databases were searched up to the end of 2010 and a total of 127 studies were included 
in the review. The findings are used as inputs for designing the model and helped 
inform subsequent analyses in the next chapters. The published version of the review 
is presented below, followed by a summary of key findings and its implications on this 
research. The references located at the end of the published review are independent of 
other citations found in this chapter. 
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2.5.2. Summary of findings 
The first study on modelling HIV spread among MSM was published in 1986 [36] and 
no major improvements in modelling methodology can be identified after 2003. There 
are only three studies that explicitly take into account the partnership duration and 
concurrency through the use of the partnership-based approach [46-48], whereas only 
four studies attempted to predict the HIV epidemic in MSM in the UK [40,51-53] and 
all dated back before 1991. Updating the study by searching the same literature 
databases found only two HIV MSM modelling studies in the UK between the 
beginning of 2011 and the end of 2013 [54,55]. This provides an opportunity for this 
research to update the predictions and provide more recent insights into HIV spread 
among UK MSM. Moreover, there were only a small number of studies that validated 
the models and the validation criteria were rather subjective. This lack of properly 
fitted and validated modelling studies highlights the need for more rigorous 
procedures for fitting and validating the model in this research. 
Several studies compared stochastic and deterministic methods and reported that the 
results were similar for epidemics that have rapid growth, a large proportion of 
infected individuals, or a large number of susceptible individuals. This suggested that 
using a deterministic approach may be appropriate for situations in which HIV is 
highly prevalent among MSM. HIV epidemics in the US, the UK, and Australia may 
provide a good example of such settings. Therefore, the deterministic modelling 
approach has been selected for model development in the next chapter. 
Modelled MSM populations were commonly categorised by sexual activity levels 
(such as partnership formation rate, contact rate), age, and therapy-related indices 
(such as treatment status, drug adherence). Multiple disease stages were mainly used 
to facilitate an incorporation of variable infectiousness and disease progression rate as 
well as to allow medications to be effective at any specific disease stages. The mixing 
matrix was the most common approach for incorporating non-random sexual mixing 
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behaviour between different groups of MSM. All these population stratifications were 
incorporated into the model along with other classifications presented in Chapter 3. 
Several studies confirmed that the following factors have a substantial impact on HIV 
epidemic estimates: variable disease progression rate, variable infectiousness due to 
disease stage, sexual contact rate, unsafe sexual practices, sexual mixing pattern, 
partnership concurrency, and increased ART usage rate, all of which have been taken 
into account in this research. There were still contradictions between studies for 
whether primary HIV infection or late infection is the predominant factor to influence 
HIV infection in a society, as well as the magnitude of the increase in unsafe sex that 
would offset the benefit of using ART to prevent new infections. Chapter 5 and 6 
addresses these issues in details. 
Finally, a combination of various HIV control strategies, i.e. sexual behavioural 
change campaign and monitoring system, HIV testing, and ART, was strongly 
recommended in several settings. However, disease eradication is unlikely even in the 
long-run and with effective combination interventions. This research explores the 
impact of HIV prevention interventions in UK MSM in Chapter 6. 
2.6. Conclusion 
The literature reviews in this chapter provide information necessary for designing a 
model as well as essential heterogeneities that should be incorporated. In the next 
chapter, I utilise this information to develop the mathematical model for HIV 
transmission and control among UK MSM. 
 
  
  
 
 
Chapter 3 :  Model development 
 
Model development 
 
In this chapter: 
 The structure of the new model 
MSM population stratification 
Model equations and calculations 
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3.1. Introduction 
This chapter presents the details underlying the structure of the HIV transmission 
model and all required calculations. This chapter has been submitted to AIDS as 
supplementary materials for the publication presented in Chapter 5. The contents 
presented in this chapter are kept in almost the same format and wording as in the 
submitted draft. Only slight modifications were carried out to comply with the thesis 
regulations. 
3.2. Overview of the HIV transmission model 
A mathematical model of the HIV transmission dynamics among men who have sex 
with men (MSM) aged 15-64 in the United Kingdom was developed based on a 
system of differential equations. A number of behavioural and biological 
heterogeneities were included in the model to simulate the epidemic over the 20-year 
time course from 2001 to 2020. The simulations were started from the beginning of 
2000 to allow the model to become more stable before conducting further analyses 
from 2001 onwards. In Chapter 4, the model is parameterised based on available 
information from multiple sources including behavioural surveys, surveillance 
systems, and the literature. It is also fitted to the data and external estimates in Chapter 
5 using the Monte-Carlo filtering method [56]. The model is used to estimate the 
current epidemic situation in various aspects and project how it would evolve in the 
near future (Chapter 5 and 6). 
3.3. Key assumptions 
A number of assumptions were made throughout the model. The main assumptions 
that this model was based on are as follows: 
 The model is a deterministic population-based model therefore the members of 
any subgroups all share the same characteristics. 
Narat Punyacharoensin         Chapter 3: Model Development 
43 
 
 MSM get infected with HIV only through anal or oral intercourse in a sexual 
partnership with a man. 
 The model allows only two types of sexual partnership: one-off and repeat 
sexual partnership (the definitions are provided in Section 3.4.4). 
 Concurrency of the same partnership types (one-off and repeated) is not 
allowed (serial monogamy). 
 Anal-sex partnerships involve only anal sexual intercourse. Similarly, oral-sex 
partnership involves only oral sexual intercourse. 
 All HIV-positive MSM start from the first disease stage (primary HIV 
infection) and progress to the next stages with decreased CD4 cell counts. The 
model does not allow an increase in CD4 cell counts. 
 Once treated, individuals remain in the treatment stage until removed from the 
model. 
 The sensitivity and specificity of the HIV test is 100%. 
 Safe sex refers to sexual intercourse with condom use. Unsafe or unprotected 
sex refers to sexual intercourse without condom use. 
 No HIV infection from outside the UK is included. 
 The HIV epidemic in the UK was modelled as a whole and there was no 
differentiation by geographic area. 
3.4. Model structure 
Structuring the model concerns stratification of the modelled population according to 
various characteristics that have an essential effect on the model outputs [43]. The 
entire MSM populations in the UK were stratified simultaneously by MSM types, age, 
sexual activity level, partnership status, and HIV-related status. 
3.4.1. Current and past MSM 
Homosexual men in general have been considered at high risk for HIV infection 
specifically because of the frequent anal sexual intercourse they have. However, a 
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considerable number of UK homosexual males have never had anal sex with men and 
their last sex (defined as a genital contact) with men was more than 5 years ago [57]. 
These were excluded from the model. Those who have had sex with men in the last 5 
years are included as ‗current‘ MSM. Those who have had sex with men but not in the 
last 5 years and also who last had anal sex more than 5 years ago are less likely to 
contribute to further HIV transmission and were defined as ‗past‘ MSM. Only current 
MSM acquire new partners and are at risk of HIV infection. The characteristics of past 
MSM resemble that of current low-activity MSM. All MSM in the model are the 
summation of the current and past MSM. 
3.4.2. Age 
The age range of the modelled population was 15-64 years and they were divided into 
two age groups of 15-34 and 35-64 years. Individuals in the younger group progress to 
the older group and individuals in the older group move out of the system at constant 
rates over time. 
3.4.3. Sexual activity level 
Two levels of sexual activity—low and high— was defined based on the number of 
sexual partners per year. The low-activity MSM have the average new male sexual 
partner per year of less than or equal to one. The high-activity MSM have more than 
one new male sexual partner per year. Together with the two age groups a total of four 
‗classes‘ of MSM in this model were formed, i.e. age group 1 – low activity, age group 
1 – high activity, age group 2 – low activity, and age group 2 – high activity. 
3.4.4. Partnership status 
I distinguished between one-off and repeat sexual partners by defining that the one-off 
sexual partnership is a relationship that has only a single sexual contact which is 
assumed to start and end instantaneously. The repeat sexual partnership is defined as a 
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relationship in which sexual contact occurs more than once, such as a married couple, 
a steady partnership, or a casual partnership that has several sexual encounters. Unlike 
the typical mean-field model, the partnership-based model [44,46] allows a repeat 
sexual partnership to last for a finite duration of time, and only during that period can 
HIV transmission between partners can occur. Both individuals with and without a 
repeat sexual partner can have one-off sexual encounter and therefore be at risk for 
HIV infection. 
3.4.5. Disease stage and CD4 levels 
Based primarily on the CD4 cell counts, the long and variable natural history of HIV 
infection was divided into five stages: primary HIV infection (PHI), CD4 500, 350-
499, 200-349, and <200 cells/µL. This allowed us to distinguish among disease stages 
with respect to the three important factors: HIV transmission probability, HIV 
diagnosis rate, and the rate of initiating antiretroviral treatment (ART), determining 
the outcomes of the model. HIV-positive men progress from the first stage through the 
last without going backward. I assumed no CD4 stratification for MSM on treatment. 
3.4.6. HIV diagnosis and treatment status 
The five disease stages were further stratified into undiagnosed and diagnosed MSM. 
The latter was split into those who have never and ever been treated with ART. Note 
that ART-treated MSM included all men who have ever been treated with ART 
regardless of their current ART status. Furthermore, the model does not allow 
individuals to move back to the previous stages in which no ART is administered. 
Taken together, there are 12 different stages of HIV infection illustrated schematically 
in Figure 3-1. 
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3.5. Model equations and calculations 
The model was constructed based on a set of ordinary differential equations. The 
numbers of single current MSM and single past MSM are denoted as Y and Z, 
respectively. The total numbers of single MSM, X Y Z  . Let P be the numbers of 
pairs (not individuals) of current MSM. The total number of MSM in the model, 
2N X P  . The subscripts , ,j k h  of , ,j k hX  are denoted as age group (j=1 for age 
group 1, j=2 for age group 2), sexual activity group (k=1 for low-activity group, k=2 
for high-activity group), and HIV infection stages ( 1, ,12h   according to 12 HIV 
stages presented in Figure 3-1: 1=susceptibles, 2=undiagnosed PHI, 3=diagnosed PHI, 
4=undiagnosed CD4>500, 5=diagnosed CD4>500, 6=undiagnosed CD4 350-499, 
7=diagnosed CD4 350-499, 8=undiagnosed CD4 200-349, 9=diagnosed CD4 200-349, 
10=undiagnosed CD4<200, 11=diagnosed CD4<200, and 12=on treatment). The 
superscripts , ,m n r  of the numbers of pairs 
, ,
, ,
m n r
j k hP  are denoted as age group m, sexual 
activity group n, and HIV stages r of the repeat sexual partner, and that 
, , , ,
, , , ,
m n r j k h
j k h m n rP P . 
This partnership-based model consists of 1,296 compartments which, following 
Xiridou et al [47] and Powers et al [58], can be described by the 46 equations listed in 
the appendix of this chapter. All parameters are summarised in Table 3-1. The time 
step in the model is a day ( =1/365=0.0027). For any per-year rates, multiplying by 
  will result in the corresponding rates per time-step. 
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Figure 3-1: Model flow diagram 
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Table 3-1: Model parameters 
Parameter Definition 
, ,j k hN  
Total number of MSM in age group j, sexual activity group k, and HIV stage h 
, ,j k hX  
Total number of single MSM in age group j, sexual activity group k, and HIV stage h 
, ,j k hY  
Number of current single MSM in age group j, sexual activity group k, and HIV stage h 
, ,j k hZ  
Number of past single MSM in age group j, sexual activity group k, and HIV stage h 
, ,
, ,
m n r
j k hP  
Number of pairs between an individual of age group j, sexual activity group k, and HIV 
stage h and an individual of age group m, sexual activity group n, and HIV stage r 
,j kv  Influx of new susceptibles in age group j (j=1), and sexual activity group k 
,j k  
Number of current MSM in age group j, and sexual activity group k (k=1) moving to 
past MSM 
j  Ageing rate from an individual in age group j to next age group or out of the model 
,j h  Mortality rate of an individual in age group j and HIV stage h 
h  
Disease progression rate of an individual in disease stage h (h=2,...,11) to the next 
stage 
, ,j k h  
HIV diagnosis rate of an individual in age group j, sexual activity group k, and 
undiagnosed stage h (h=2,4,6,8,10)  
ks  
The proportion of MSM in sexual activity group k who switch to another sexual 
activity group after being diagnosed with HIV 
h  ART initiating rate of an individual in diagnosed stage h (h=5,7,9,11)  
,
rep
j k  
Repeat sexual partnership formation rate of an individual in age group j, and sexual 
activity group k 
,j k  
Repeat sexual partnership dissolution rate of an individual in age group j, and sexual 
activity group k 
, , ,
, ,
rep m n r
j k h  
Chance of an individual in age group j, sexual activity group k, and HIV stage h to 
acquire a repeat sexual partner of age group m, sexual activity group n, and HIV stage r 
, , ,
,
one m n r
j k  
Chance of a susceptible in age group j, and sexual activity group k to acquire a one-off 
sexual partner of age group m, sexual activity group n, and HIV stage r 
, ,
one
Y j k  
Force of infection in a relationship between a one-off sexual partner and a single 
susceptible individual of  age group j, and sexual activity group k 
, ,
one
P j k  
Force of infection in a relationship between a one-off sexual partner and a paired 
susceptible individual of  age group j, and sexual activity group k 
, , ,
,
rep m n r
j k  
Force of infection in a relationship between a repeat sexual partner of age group m, 
sexual activity group n , and disease stage h (h=2,...,1) and a susceptible individual of  
age group j, and sexual activity group k 
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3.5.1. Calculating ageing 
For each time step, individuals progress from the first to the second age group, and are 
removed out of the model from the second age group according to the proportion of 
MSM at the maximum age to all MSM in each age group. The derivation of the 
proportion is described in Section 4.3.1.2. Note that per-year rates must be converted 
to per-time step before being used as model input. 
3.5.2. Calculating mortality 
The death rate, 
,j h , stratified by age group and HIV stage is applied directly to the 
numbers of MSM in each corresponding group (see Section 4.3.1.4 for details of 
mortality rate). The number of deaths is subtracted from the model every time step and 
used for calculating the influx of new MSM. 
3.5.3. Calculating influx of new MSM 
A set of new MSM enters the model every time step and becomes a part of age group 
1. This influx is calculated from the summation of the number of individuals who age 
from age group 1, those who die while in age group 1, and growth per time step of age 
group 1. The formula used is as follows: 
      1, 1 1 1 1,
( )k kg N                 (14) 
where 
1,kN  is the total number of MSM in age group 1 and sexual activity group k and 
1g  is the growth rate of age group 1. See Section 4.3.1.3 for derivation of the 
population growth rate. 
3.5.4. Calculating transition from the current to past MSM 
A transition from the current to past MSM was modelled based on the assumption that 
the ratio between past and current MSM remains fixed over time (See Section 0 for 
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more detail about finding the ratio). Every time step the ratio 
,
,
j h
j h
Z
Y
 is updated. If any 
updated ratios are less than that of the initial time step, a number of current MSM from 
age group j and HIV stage h will be moved to the same group of past MSM to preserve 
the original ratio. According to the definition of the past MSM (Section 3.4.1), only 
current MSM of low-activity group (See Section 4.3.2.1 for the definition) are 
legitimate for such movement. The numbers of past and current MSM of any groups 
remain unchanged if the updated ratio equals or exceeds that of the initial one. The 
model assumed no transition from past to current MSM. 
3.5.5. Calculating disease progression 
HIV-positive MSM progress from one disease stage to another according to declined 
CD4 cell counts (Figure 3-1). Multiplying the progression rate, h , (Section 0) by the 
number of individuals in each disease stage ranging from PHI to CD4 200-349 
cells/µL yields the number of MSM approaching the more advanced stages of HIV. 
Those with CD4<200 cells/µL remain in the last stage until they were either removed 
from the model by ageing or death, or get HIV diagnosed. 
3.5.6. Calculating new HIV diagnoses 
During the model year 2000–2009, the rates that HIV-positive MSM get diagnosed 
with HIV are updated every time step with an increase in diagnosis rate. I derived 
changes in HIV diagnosis rate (Section 4.3.4) and then updated the time-dependent 
HIV diagnosis rates by: 
     
, , , , , ,( ) ( 1) ( )j k h j k h j k ht t t                (15) 
where 
, , ( )j k h t  represents change in diagnosis rate from time step t-1 to t. MSM 
newly diagnosed with HIV each time step move from undiagnosed CD4 stages to the 
corresponding diagnosed stages. I also compared model outputs to the reported 
numbers of new diagnoses by CD4 to validate the model (Chapter 5). 
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The model also allows current MSM to change their sexual activity levels due to HIV 
diagnosis. The constant proportions of individuals who switch from high- to low-
activity group and vice versa, 
,j ks (see Section 4.3.4 for parameter values), were 
applied directly and instantly to the number of new diagnoses in each time step to 
obtain the number of MSM moving between sexual activity levels. Switching between 
sexual activity levels was permanent and thus individuals were not able to move back 
to the previous sexual activity levels. 
3.5.7. Calculating MSM getting ART- treated 
The diagnosed MSM in any CD4 stages except the PHI are given ART treatment 
every time step at the different rates, h , with men in more advanced stages being 
more likely to be treated with ART. MSM new to treatment moved to a single 
compartment of ‗on treatment‘ stage that no longer stratified by CD4 cell counts. 
Having no CD4 stratification is believed to have only a minor effect on the model 
outcome since the transmission probability of ART-treated MSM is very low, 
particularly in developed countries. This also helped simplify this model that already 
consists of a considerable number of heterogeneities. The rates of ART initiation 
change according to the updated guidelines for HIV treatment in the UK in 2008 [59]. 
The new rates were used once the model ran into the year 2009 and remain unchanged 
until the end of simulation. Section 4.3.5 summarises the derivation of ART initiating 
rates. 
3.5.8. Calculating formation and dissolution of repeat sexual partnerships 
The chance of an individual in any of the classes and stages to choose a repeat sexual 
partner from the same or another group is calculated based on two main components: 
the repeat sexual partnership formation rate and the sexual mixing preference. The 
odds ratio approach suggested by Goodreau and Golden [48] is used due to its 
flexibility in modelling multidimensional mixing preferences. The method also 
ensures that, at any modelling time steps, the number of new repeat sexual partners 
Narat Punyacharoensin  Chapter 3: Model Development 
52 
 
that MSM of group m acquire from group n is identical to that of MSM of group n 
acquire from group m [60]. 
The mixing preferences by age group, sexual activity level, and the perceived HIV 
serostatus are included in the model. Each type consists of 2 subgroups: age group 
consists of the age group 1 and 2, sexual activity level consists of the low-activity and 
high-activity group, and the perceived HIV serostatus consists of the groups of 
perceived HIV-negative (stage S, and U1 to U5) and diagnosed HIV-positive (stage 
D1 to D5, and T). Consequently, the three odds ratios based on 2x2 mixing matrix for 
each mixing preference are required. The method for deriving the odds ratio can be 
found in Section 4.3.2.7. For simplicity, each mixing preference was modelled 
independently so that when all other mixing preferences are discarded, the chance of 
MSM selecting a new repeat sexual partner from the same or different groups matches 
exactly the original odds ratio of the remaining mixing preference. 
At each time step, the calculations were initiated by finding the number of MSM who 
are looking for a new repeat sexual partner and stratified independently by age group, 
sexual activity level, and the perceived HIV serostatus. These numbers were then 
allocated between groups and created the following mixing matrix for each mixing 
preference: 
 
Group 1 Group 2 
Group 1 a b 
Group 2 c d 
The matrix shows the number of MSM in pairs between the two groups. If the odd 
ratios ad/bc is greater than one the mixing is assortative, i.e. an individual is more 
likely to select a partner from their own group rather than from the other groups. Odds 
ratio of less than one represents the disassortative mixing, i.e. an individual is more 
likely to select a partner from the other groups rather than their own group. Odds ratio 
of one represents proportionate mixing, i.e. an individual selects a partner based on the 
proportion of group 1 and 2 to all available men. The elements of the mixing matrix 
are calculated by: 
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1 1
repa Y b    (16) 
 
 
2
1 1 1
1 1 2 2 1 1 2 2 1 1 2 22 2 4
( 1)
,
1
rep rep rep rep rep repY Y Y Y Y Y w
b b c
w
          
 

 (17) 
 
2 2
repd Y b   (18) 
where rep
i  is the average repeat sexual partner formation rate of group i, iY  is the 
number of current MSM in group i, and w is the odds ratio of the mixing preference. 
I then combined any two of the three mixing preferences based on the assumption that 
the odds ratio of any type in any subgroup is identical to the same odds ratio in the 
overall population. In practice, I assigned the one mixing matrix to all elements of 
another mixing matrix and, within each of those elements of the latter matrix, 
calculated the mixing by the former matrix. For example, if mixing matrices by age 
group and sexual activity are: 
Age Group 1 Group 2  Activity Group 1 Group 2 
 Group 1 a = A1 b = A2   Group 1 a = B1 b = B2 
Group 2 c = A3 d = A4  Group 2 c = B3 d = B4 
the sexual activity mixing matrix in an element a of age mixing matrix is: 
 
Group 1 Group 2 
Group 1 k×B1 k×B2 
Group 2 k×B3 k×B4 
where 
B1 B2 B3 B4
A1
k
  
 . The resulting odds ratio of this sub-matrix equals the 
overall age-mixing odds ratio. The calculations for other elements and for combining 
all three mixing preferences can be achieved using the same logic. Note the order of 
combining the three mixing preferences has no effect on the final mixing matrix. 
The combined 8x8 mixing matrix contains the numbers of MSM in repeat sexual 
partnerships between MSM of 8 subgroups stratified simultaneously by two age 
groups, two sexual activity levels, and two perceived HIV serostatuses. Comparing the 
partnership formation rates derived from the combined mixing matrix to the original 
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parameter values revealed some inconsistencies between the two sources which 
necessitated further adjustments. I therefore adjusted the numbers of men required for 
forming repeat sexual partnerships from the eight subgroups by multiplying the 
mixing elements that contribute the total number of required MSM in each subgroup 
with the ratio between original (data-derived) and actual repeat sexual partnership 
formation rates. The mixing elements are adjusted using the following formula: 
 
,, , , ,
, , , ,
,
rep
j km n q m n q
j k p j k p rep
j k
a a




            (19) 
where , ,
, ,
m n q
j k pa  is a mixing element before adjustment between men of age group j, 
sexual activity group k, and perceived HIV serostatus group p and men of the 
corresponding groups m, n, and q, respectively, ,
rep
j k  is the original (data-derived) 
repeat sexual partnership formation rate for men in age group j and sexual activity 
group k, and ,
rep
j k  is the partnership formation rate that derived from the combined 
mixing matrix. The above equation shows that all the non-diagonal elements                 
([ , , ] [ , , ]j k p m n q ) contribute concurrently to two mixing subgroups; I decided to 
adjust the subgroup that has a largest deviation of the partnership formation rates, 
,
,
1
rep
j k
rep
j k




, at each time step. After adjustment, the repeat sexual partnership formation 
rates of the subgroup that has the largest deviation would be identical to that of the 
original rate. The deviations in other subgroups may still remain but considerably 
smaller than without the adjustment. In exchange for more precise partnership 
formation rates, all types of odds ratio in the overall populations began to shift from 
the original values. However, the benefit of adjustment is clear since an improvement 
in accuracy of partnership formation rates after adjustment is substantial while only a 
minor difference in the odds ratio can be found. This is because the adjustment was 
aimed at subgroups with large deviations which usually are of small size and, in turn, 
having less effect on the odds ratio. 
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The final mixing matrix can now be used to obtain , , ,
, , , , ,
rep m n r rep
j k h j k j k hY  . Since the 
proportionate mixing by disease stage was assumed, the numbers of repeat sexual 
partnerships were allocated proportionally to all pairs within each of the eight 
subgroups. In order for  , , , ,
, , , ,
m n r j k h
j k h m n rP P  to remain valid at all times, the condition 
, , , , , ,
, , , , , , , , , ,
rep m n r rep rep j k h rep
j k h j k j k h m n r m n m n rY Y     must always be satisfied. This can be achieved by 
using the adjusted repeat sexual partnership formation rates instead of one originally 
derived from the data in the main model equations. 
The breakup between repeat sexual partners occurs every time step at the rate 
,j k . 
The two members of a separated pair move to the single state and are ready for a new 
repeat sexual partnership. An average gap period between the end of the last repeat 
sexual partnership and the beginning of the next is incorporated to the dissolution rate 
to reflect the fact that, after the end of a long relationship, individual stays single for 
some period of time before acquiring a new partner. 
3.5.9. Calculating force of infection in repeat sexual partnerships 
In the partnership-based HIV transmission model, the force of infection for a repeat 
sexual partnership consists of two main components: the transmission probability and 
the frequency of sexual acts. The HIV transmission probabilities for each of the 
disease stages were calculated from a function of the average viral load in that stage 
(Section 4.3.3). Combining with all related factors, the per-act HIV transmission 
probability from an HIV-positive man of age group m (m=1,2), sexual activity n 
(n=1,2) and disease stage r, (r=2,...,12) to a susceptible of age group j (j=1,2), and 
sexual activity k (k=1,2) was calculated by: 
, , ,
, , , , , , , ,
, , , , ,
, , , , ,
[ ( ) (1 )
(1 )( ) (1 ) )]
(1 )[ ]
ste m n r rep rep
j k anal j k uai j k r ins uiai r ins urai r
rep
cdm uai j k r ins uiai r ins urai r
rep rep
anal j k uroi j k uroi r
p p p p
p p p
p p
  
  

  
   
 
         (20) 
The notations are summarised in Table 4-7, Table 4-9, and Table 4-10. 
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The force of infection per time step is the product of the combined HIV per-act 
transmission probability and the average frequency of sexual acts per time step 
between MSM of class j and k, 
,j k : 
  , , , , , ,
, , ,
rep m n r rep m n r
j k j k j k                   (21) 
The force of infection was calculated for all pairs between HIV-positive and HIV-
negative MSM. Newly HIV-infected MSM at each time step move from HIV stage S 
to U1 while retain the current repeat sexual relationship. 
3.5.10. Calculating formation and force of infection in one-off sexual 
partnerships 
The same method used for the repeat sexual partnership formation is used to calculate 
the formation of one-off sexual partnership. Both single and paired MSM acquired a 
new one-off sexual partner at different rates. For paired MSM, only high-activity 
group members can form a one-off relationship while having a repeat sexual partner. 
Only mixing by age group and sexual activity were incorporated. The perceived HIV 
serostatus was accounted for differently by subsequently dividing MSM into 
subgroups according to unprotected anal intercourse (UAI) with one-off sexual 
partners. Within each perceived HIV serostatus, proportionate mixing by HIV stage 
was assumed. 
The mixing matrices and one-off sexual partnership formation rates were adjusted in 
the same manner as for the formation of repeat sexual partnership. From the final 
mixing matrix I derived a chance of selecting a one-off sexual partner from different 
age and sexual activity groups, , , ,,
one m n r
j k . This was subsequently used to formulate the 
force of infection in one-off sexual partnerships. The one-off sexual partnerships were 
assumed to form and separate instantaneously, and hence a dissolution rate was not 
required. 
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To derive the force of infection within one-off sexual partnerships, susceptibles were 
divided into three groups: (A) no UAI at all, (B) only have UAI with perceived HIV-
negative partners, and (C) can (but not only) have UAI with diagnosed HIV-positive 
partners. This allows us to model serosorting in one-off sexual partnership more 
comprehensively. The members of group A perform only safe anal sex regardless of 
the perception they have of their one-off sexual partner‘s serostatus. Group B will only 
have UAI with one-off sexual partners they believe are HIV negative (serosorting). 
However, it is not necessary that men of group B will always have UAI with an HIV-
negative one-off sexual partner. Group C can have UAI with one-off sexual partners of 
any HIV serostatuses. The expression for the combined HIV transmission probability 
in one-off sexual partnerships that accounted for all UAI groups is given by: 
,
, , , , , , , , , , , , , ,
one all one one one one one one
G j k A G G A j k B G G B j k C G G C j kp p p                 (22) 
where ,
one
A Gp , ,
one
B Gp , and ,
one
C Gp  is the proportion of men in group A, B and C, 
respectively, and ,G Y P  denotes current single and paired MSM. The HIV 
transmission probabilities for each UAI group are: 
2 2 12
, , ,
, , , , , ,
1 1 2
one one m n r one
G A j k cdm j k G j k
m n r
   
  
               (23) 
2 2 12
, , ,
, , , , , , , , , ,
1 1 2
2 2
, , ,
, , , , , , ,
1 1
( (1 ) )
( )
one one one m n r one
G B j k cdm uai G B j k j k G j k
m n r
one one m n r one
uai G B j k j k G j k
m n r d
p
p
   
 
  
  
 



  
where 1,2,4,6,8,10d                  (24) 
2 2 12
, , ,
, , , , , , , , , , , , , ,
1 1 2
( (1 ) )one one one one m n r oneG C j k cdm uai G C j k uai G C j k j k G j k
m n r
p p   
  
            (25) 
The common term of transmission probability shared by all three groups is given by 
the expression: 
, , , , , , , , ,
, , , , , ,
[ ( (1 )) (1 ) ]
(1 )[ ]
one one
G j k anal G j k ins uiai r cir j cir cir j ins urai r
one one
anal G j k uroi j k uroi r
p p p p p
p p
   

    
 
       (26) 
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The force of infection per time step is the product of one-off sexual partnership 
formation rates and the combined HIV transmission probabilities: 
,
, , , , , ,
one one one all
G j k G j k G j k       
            (27) 
The notations used here are summarised in Table 4-7. 
3.6. Conclusion 
Up to this point, all computational mechanisms of the model have been developed. 
The model parameters defined in this chapter will be estimated in the next two 
chapters. 
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3.7. Appendix 
3.7.1. Differential equations 
Note that [ , ] [ , ]j k m n  in all equations below, and the {condition} denotes a specific condition that must be satisfied to enable the corresponding 
term. 
Current single MSM 
2 2 12
, ,1 , ,1 , ,
, , ,1 , , ,1 , ,1 1 1, ,1 ,1 , , , , ,1
1 1 1
{ 1} { 1} ( ) { 2} ( )
j k j k m n r rep one
j k j k j k j k j k j j k j j j k Y j k j k
m n r
dY
j k P P Y j Y
dt
        
  
                       (28) 
2 2 12
, ,2 , ,2 , ,
, , ,2 , ,2 1 1, ,2 , , , ,1 ,2 2 , ,2 , , ,2
1 1 1
( ) { 2} ( )
j k j k m n r one rep
j k j k j k j j k Y j k j k j j j k j k j k
m n r
dY
P P Y j Y Y
dt
        
  
                       (29) 
2 2 12
, ,3 , ,3 , ,
, , ,3 , ,3 1 1, ,3 , ,2 , ,2 , ,2 , ,2 ,3 3 , , ,3
1 1 1
( ) { 2} (1 ) { } ( )
j k j k m n r rep
j k j k j k j j k k j k j k l j l j l j j j k j k
m n r
dY
P P Y j s Y s Y l k Y
dt
        
  
                        (30) 
2 2 12
, , , , , ,
, , , , , , , 1 1, , 2 , , 2
1 1 1
, , , , , ,
{ 1} ( ) { 2}
( { 10} )
j k h j k h m n r
j k h j k j k h j k h j j k h h j k h
m n r
rep
j j h h j k h j k j k h
dY
k P P Y j Y
dt
h Y
   
    
   
  
       
     

        
for h = 4, 6, 8, 10.      (31) 
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2 2 12
, , , , , ,
, , , , , , , 1 1, , , , 1 , , 1 , , 1 , , 1
1 1 1
2 , , 2 , , , ,
{ 1} ( ) { 2} (1 ) { }
( { 11} )
j k h j k h m n r
j k h j k j k h j k h j j k h k j k h j k h l j l h j l h
m n r
rep
h j k h j j h h h j k j k h
dY
k P P Y j s Y s Y l k
dt
Y h Y
    
     
     
  
 
          
      

  for h = 5, 7, 9, 11.      (32) 
2 2 12
, ,12 , ,12 , ,
, ,12 , , ,12 , ,12 1 1, ,12 , , ,12 , , ,12
1 1 1
{ 1} ( ) { 2} ( )
j k j k m n r rep
j k j k j k j k j j k g j k g j j j k j k
m n r g s
dY
k P P Y j Y Y
dt
       
   
              where s = 5, 7, 9, 11.     (33) 
Past MSM 
,1,1
,1 1 1,1,1 ,1 ,1,1{ 2} ( )
j
j j j j j j
dZ
Z j Z
dt
                                 (34) 
,1,2
,2 1 1,1,2 ,2 2 ,1,2 ,1,2{ 2} ( )
j
j j j j j j j
dZ
Z j Z
dt
                              (35) 
,1,3
,3 1 1,1,3 ,1,2 ,1,2 ,3 3 ,1,3{ 2} ( )
j
j j j j j j j j
dZ
Z j Z Z
dt
                              (36) 
,1,
, 1 1,1, 2 ,1, 2 , ,1, ,1,{ 2} ( { 10} )
j h
j h j j h h j h j j h h j h j h
dZ
Z j Z h Z
dt
                          for h = 4, 6, 8, 10.      (37) 
,1,
, 1 1,1, ,1, 1 ,1, 1 2 ,1, 2 , ,1,{ 2} ( { 11} )
j h
j h j j h j h j h h j h j j h h h j h
dZ
Z j Z Z h Z
dt
                            for h = 5, 7, 9, 11.      (38) 
,1,12
,12 1 1,1,12 ,1, ,12 ,1,12{ 2} ( )
j
j j j g j g j j j
g s
dZ
Z j Z Z
dt
     

              where s = 5, 7, 9, 11.     (39) 
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Paired MSM 
Susceptible (HIV stage no.1) – Susceptible (HIV stage no.1) 
, ,1
, ,1 , , ,1 , ,1 , ,1
, ,1 , , ,1 1 1, ,1 ,1 , , , , ,12 { 2} (2 2 2 )
j k
j k rep j k rep j k one j k
j k j k j k j j k j j j k P j k j k
dP
Y P j P
dt
                               (40) 
, ,1
, ,1 , ,, , ,1 , ,1 , ,1 , ,1
, ,1 , , ,1 1 1, ,1 1 1, ,1 ,1 ,1 , , , , , ,1{ 2} { 2} ( )
2
m n
j k j k m nrep m n rep m n j k one one m n
j k j k j k j j k m m n j m j m P j k P m n j k
dP
Y P j P m P
dt
 
            

                     (41) 
Susceptible (HIV stage no.1) – Infected (HIV stage no.2-12) 
, ,2
, ,1 , , ,2 , ,2 , ,1 , , ,2 , ,2
, ,1 , , ,1 1 1, ,1 , , , ,1 ,1 ,2 2 , ,2 , , , , , ,12 { 2} 2 (2 )
j k
j k rep j k rep j k one j k one rep j k j k
j k j k j k j j k P j k j k j j j j k j k P j k j k j k
dP
Y P j P P
dt
                                  (42) 
, ,2
, ,1 , , ,2 , ,2 , ,1 , ,1
, ,1 , , ,1 1 1, ,1 1 1, ,2 , , , , , ,1
, , , , ,2 , ,2
,1 ,2 2 , ,2 , , , , ,1
{ 2} { 2} ( )
( )
2
m n
j k rep m n rep m n j k one one m n
j k j k j k j j k m m n P j k P m n j k
j k m n one rep m n m n
j m j m m n P j k j k j k
dP
Y P j P m P
dt
P
     
 
       
         

        
                (43) 
, ,3
, ,1 , , ,3 , ,3 , ,2 , ,2 , , ,3 , ,3
, ,1 , , ,1 1 1, ,1 , ,2 , ,1 , ,2 , ,1 ,1 ,3 3 , , , , , ,12 { 2} (1 ) { } (2 )
j k
j k rep j k rep j k j k j l one rep j k j k
j k j k j k j j k k j k j k l j l j k j j j j k P j k j k j k
dP
Y P j s P s P l k P
dt
                                (44) 
, ,3
, ,1 , , ,3 , ,3 , ,1 , ,2 , ,2
, ,1 , , ,1 1 1, ,1 1 1, ,3 , ,2 , ,1 , ,2 , ,1
, , , , ,3
,1 ,3 3 , , , , ,1
{ 2} { 2} (1 ) { }
( )
2
m n
j k rep m n rep m n j k m n m l
j k j k j k j j k m m n n m n j k l m l j k
j k m n one rep m n
j m j m P j k j k j k
dP
Y P j P m s P s P l n
dt
P
     
 
      
           

        , ,3m n
            (45) 
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, ,
, ,1 , , , , , , , 2
, ,1 , , ,1 1 1, ,1 2 , ,1
, , , , ,
,1 , , , , , , , , ,1
2 { 2}
(2 { 10} )
j k h
j k rep j k h rep j k h j k h
j k j k j k j j k h j k
one rep j k h j k h
j j j h h j k h j k P j k j k j k
dP
Y P j P
dt
h P
   
       

     
        
         for h = 4, 6, 8, 10.     (46) 
, ,
, ,1 , , , , , , ,1 , , 2
, ,1 , , ,1 1 1, ,1 1 1, , 2 , ,1
, , , , , , ,
,1 , , , , , , , ,1
{ 2} { 2}
( { 10} )
2
m n r
j k rep m n r rep m n r j k m n r
j k j k j k j j k m m n r r j k
j k m n one rep m n r m n r
j m j m r r m n r P j k j k j k
dP
Y P j P m P
dt
r P
    
 
       

         

         
        for r = 4, 6, 8, 10.     (47) 
, ,
, ,1 , , , , , , , 2 , , 1 , , 1
, ,1 , , ,1 1 1, ,1 2 , ,1 , , 1 , ,1 , , 1 , ,1
, , ,
,1 , , , , ,
2 { 2} (1 ) { }
(2 { 11} )
j k h
j k rep j k h rep j k h j k h j k h j l h
j k j k j k j j k h j k k j k h j k l j l h j k
one rep j k h
j j j h h h j k P j k j k
dP
Y P j P s P s P l k
dt
h P
     
       
  
           
         , ,, ,1
j k h
j k
     for h = 5, 7, 9, 11.     (48) 
, ,
, ,1 , , , , , , ,1 , , 2 , , 1 , , 1
, ,1 , , ,1 1 1, ,1 1 1, , 2 , ,1 , , 1 , ,1 , , 1 , ,1
,
,1 ,
{ 2} { 2} (1 ) { }
( { 11}
m n r
j k rep m n r rep m n r j k m n r m n r m l r
j k j k j k j j k m m n r r j k n m n r j k l m l r j k
j k
j m j m r r r
dP
Y P j P m P s P s P l n
dt
r
      
 
     
  
               

       
, , , , , ,
, , , , ,1)
2
m n one rep m n r m n r
P j k j k j kP  
 
for  r = 5, 7, 9, 11.     (49) 
, ,12
, ,1 , , ,12 , ,12 , , , , ,12 , ,12
, ,1 , , ,1 1 1, ,1 , ,1 ,1 ,12 , , , , , ,12 { 2} (2 )
j k
j k rep j k rep j k j k g one rep j k j k
j k j k j k j j k g j k j j j j k P j k j k j k
g s
dP
Y P j P P
dt
          

             where s = 5, 7, 9, 11.  (50) 
, ,12
, ,1 , , ,12 , ,12 , ,1 , ,
, ,1 , , ,1 1 1, ,1 1 1, ,10 , ,1
, , , , ,12 , ,12
,1 ,12 , , , , ,1
{ 2} { 2}
( )
2
m n
j k rep m n rep m n j k m n g
j k j k j k j j k m m n g j k
g s
j k m n one rep m n m n
j m j m P j k j k j k
dP
Y P j P m P
dt
P
    
 
     
   

     

      

         where s = 5, 7, 9, 11.  (51) 
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Undiagnosed PHI (HIV stage no.2) – Infected (HIV stage no.2-12) 
, ,2
, ,2 , , ,2 , ,2 , , ,2 , ,2 , ,2
, ,2 , , ,2 1 1, ,2 , , , , ,1 ,2 2 , ,2 , , ,22 { 2} ( ) (2 2 2 2 )
j k
j k rep j k rep j k one rep j k j k j k
j k j k j k j j k P j k j k j k j j j k j k j k
dP
Y P j P P
dt
                               (52) 
, ,2
, ,2 , , ,2 , ,2 , ,2 , , ,2 , ,2 , , ,2 , ,1
, ,2 , , ,2 1 1, ,2 1 1, ,2 , , , , ,1 , , , , ,2
,2 ,2 2 , ,2 , ,2
{ 2} { 2} ( ) ( )
( 2
m n
j k rep m n rep m n j k one rep m n m n one rep j k m n
j k j k j k j j k m m n P j k j k j k P m n m n j k
j m j m j k m n
dP
Y P j P m P P
dt
       

      
           
       
, , , ,2
, ,2)
2
j k m n m n
j kP

          (53) 
, ,3
, ,2 , , ,3 , ,3 , ,2 , , ,3 , ,3 , ,3
, ,2 , , ,2 1 1, ,2 , ,2 , ,2 , , , , ,1 ,2 ,3 2 3 , ,2 , , ,22 { 2} 2 ( ) (2 )
j k
j k rep j k rep j k j k one rep j k j k j k
j k j k j k j j k j k j k P j k j k j k j j j j k j k j k
dP
Y P j P P P
dt
                                 (54) 
, ,3
, ,2 , , ,3 , ,3 , ,3 , ,2 , , ,3 , ,3
, ,2 , , ,2 1 1, ,2 1 1, ,2 , ,2 , ,2 , , , , ,1
, , , ,3
,2 ,3 2 3 , ,2 , ,2
{ 2} { 2} ( )
( )
2
m n
j k rep m n rep m n j k m n one rep m n m n
j k j k j k j j k m m n m n j k P j k j k j k
j k m n m n
j m j m j k j k
dP
Y P j P m P P
dt
P
      
 
      
          

       
             (55) 
, ,
, ,2 , , , , , , , 2 , , , , ,
, ,2 , , ,2 1 1, ,2 2 , ,2 , , , , ,1
, ,
,2 , 2 , ,2 , , , , ,2
2 { 2} ( )
(2 { 10} )
j k h
j k rep j k h rep j k h j k h one rep j k h j k h
j k j k j k j j k h j k P j k j k j k
j k h
j j j h h j k j k h j k j k
dP
Y P j P P
dt
h P
     
       

       
        
         for h = 4, 6, 8, 10.     (56) 
, ,
, ,2 , , , , , , ,2 , , 2 , , , , ,
, ,2 , , ,2 1 1, ,2 1 1, , 2 , ,2 , , , , ,1
, ,
,2 , 2 , ,2 , ,
{ 2} { 2} ( )
( { 10} )
2
m n r
j k rep m n r rep m n r j k m n r one rep m n r m n r
j k j k j k j j k m m n r r j k P j k j k j k
j k m n
j m j m r r j k j k r
dP
Y P j P m P P
dt
r P
      
 
       

           

          , ,, ,2
m n r
j k
     for r = 4, 6, 8, 10.     (57) 
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, ,
, ,2 , , , , , , , 2 , , 1 , , 1
, ,2 , , ,2 1 1, ,2 2 , ,2 , , 1 , ,2 , , 1 , ,2
, , , , ,
, , , , ,1 ,2 , 2
2 { 2} (1 ) { }
( ) (2
j k h
j k rep j k h ste j k h j k h j k h j l h
j k j k j k j j k h j k k j k h j k l j l h j k
one rep j k h j k h
P j k j k j k j j j h h
dP
Y P j P s P s P l k
dt
P
     
      
  
           
       , ,, ,2 , , , , ,2{ 11} )
j k h
j k j k h h j k j kh P       
     for h = 5, 7, 9, 11.    (58) 
, ,
, ,2 , , , , , , ,2 , , 2 , , 1 , , 1
, ,2 , , ,2 1 1, ,2 1 1, , 2 , ,2 , , 1 , ,2 , , 1 , ,2
, , , , ,
, , , , ,1
{ 2} { 2} (1 ) { }
( )
m n r
j k rep m n r rep m n r j k m n r m n r m l r
j k j k j k j j k m m n r r j k n m n r j k l m l r j k
one rep m n r m n
P j k j k j k
dP
Y P j P m P s P s P l n
dt
P
      
 
  
               
 
, , , ,
,2 , 2 , ,2 , ,2( { 11} )
2
j k m nr m n r
j m j m r r j k r j kr P
 
       

         
 for r = 5, 7, 9, 11.    (59) 
, ,12
, ,2 , , ,12 , ,12 , , , , ,12 , ,12
, ,2 , , ,2 1 1, ,2 , ,2 , , , , ,1
, ,12
,2 ,12 2 , ,2 , , ,2
2 { 2} ( )
(2 )
j k
j k rep j k rep j k j k g one rep j k j k
j k j k j k j j k g j k P j k j k j k
g s
j k
j j j j k j k j k
dP
Y P j P P
dt
P
     
     
 

     
     

         where s = 5, 7, 9, 11.  (60) 
, ,12
, ,2 , , ,12 , ,12 , ,2 , , , , ,12 , ,12
, ,2 , , ,2 1 1, ,2 1 1, ,12 , ,2 , , , , ,1
, , , ,
,2 ,12 2 , ,2 , ,2
{ 2} { 2} ( )
( )
2
m n
j k rep m n rep m n j k m n g one rep m n m n
j k j k j k j j k m m n g j k P j k j k j k
g s
j k m n m n
j m j m j k j k
dP
Y P j P m P P
dt
P
      
 
     
   

       

      

12     
where s = 5, 7, 9, 11.  (61) 
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Infected except U2 (HIV stage no.3-12) – Infected except U2 (HIV stage no.3-12) 
 
Undiagnosed – Undiagnosed 
, ,
, , , , , , , , , , , 2
, , , , , 1 1, , 2 , , 2 2 , ,
, ,
, , , , , , , , ,
2 { 2}
(2 { 10} { 10} )
j k r
j k h rep j k r ste j k r j k r j k r
j k h j k j k h j j k h h j k h r j k h
j k r
j j h j r h r j k h j k r j k j k h
dP
Y P j P P
dt
h r P
    
       

        
         
     for h = 4, 6, 8, 10, and r = 4, 6, 8, 10.     (62) 
, ,
, , , , , , , , , , , 2
, , , , , 1 1, , 1 1, , 2 , ,
, , , ,
, , , , , , , ,
{ 2} { 2}
( { 10} { 10} )
2
m n r
j k h rep m n r rep m n r j k h m n r
j k h j k j k h j j k h m m n r r j k h
j k m n m n r
j m j h m r h r j k h j k r j k h
dP
Y P j P m P
dt
h r P
    
 
       

         

          
   for h = 4, 6, 8, 10, and r = 4, 6, 8, 10.        (63) 
Undiagnosed – Diagnosed 
, ,
, , , , , , , , , , , 2
, , , , , 1 1, , 2 , , 2 2 , ,
, , 1 , , 1
, , 1 , , , , 1 , ,
, ,
2 { 2} { 3}
(1 ) { }
(2 { 10} { 11}
j k r
j k h rep j k r rep j k r j k r j k r
j k h j k j k h j j k h h j k h r j k h
j k r j l r
k j k r j k h l j l r j k h
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  for h = 4, 6, 8, 10, and r = 3, 5, 7, 9, 11.    (65) 
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Undiagnosed – On treatment 
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    for h = 3, 5, 7, 9, 11, and r = 3, 5, 7, 9, 11.     (69) 
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Diagnosed – On treatment 
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  for s = 5, 7,9, 11.         (73) 
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4.1. Introduction 
This chapter begins with a discussion on the available data and sources that are used 
for model parameterisation. The details on deriving parameter values according to the 
developed model from the previous chapter are then presented. The contents of this 
chapter have been published in AIDS as supplementary materials for the publication 
[61] presented in Chapter 5. 
4.2. Data 
The data from behavioural surveys and HIV surveillance systems that included men 
who have sex with men (MSM) in the UK were used in conjunction with information 
obtained from the literature to estimate model parameters. I adjusted and categorised 
data according to the MSM subgroups in the model before further analyses. 
4.2.1. Data sources 
The primary data sources for deriving model parameters are as follows. 
4.2.1.1. The National Survey of Sexual Attitudes and Lifestyles (NATSAL) 
NATSAL is a major survey of sexual attitudes and lifestyles providing detailed 
information about sexual and related behaviour patterns of the general UK populations 
aged 16-44 including MSM. This survey is conducted at ten-year intervals. The first 
round was initiated in 1990 [62], the second in 2000–2001 [57], and the third round in 
2010–2012, the results of which has been published in 2013 [63]. The data from the 
2000 survey was the primary data. 
4.2.1.2. The Gay Men’s Sexual Health Survey (GMSHS) 
Initiated in 1996, GMSHS is a survey aimed primarily at gathering information on 
demographics, sexual behaviour, and HIV status among gay men aged 16 or above 
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who attend community venues in London [64]. Since 2000, survey respondents had 
also been offered an anonymous HIV test using the OraSure device. This allows 
linking respondent‘s serostatus to the data collected from the questionnaire. I used the 
data for years 2000–2008 except 2007 when the survey was not conducted. University 
College London, PHE, and the Medical Research Council are responsible for the 
survey. 
4.2.1.3. The London Gym Survey (GYM) 
GYM is a survey on demographics, social characteristics, sexual behaviour, HIV 
status, and risk factors among gay men who use gyms in London [65]. With 
collaboration between City University London and PHE, the survey was conducted 
annually between 1998 and 2005 and again in 2008. I used all data that are available 
from 2000 to 2008. 
4.2.1.4. The HIV/AIDS diagnoses and deaths surveillance 
This is the national HIV/AIDS surveillance reporting systems established in 1982. The 
data have been reported on a regular basis including the number of new HIV 
diagnoses, laboratory tests, probable routes of infection, demographics, and 
epidemiological data [66]. The data are made available by PHE. 
4.2.1.5. The CD4 surveillance systems 
As a supplementary to the HIV/AIDS surveillance, the CD4 systems monitor trends in 
CD4 cell count at HIV diagnosis among HIV-infected adults. The CD4 cell count at 
HIV diagnosis is defined as the CD4 cell count closest to, and within 30 days of, the 
date of HIV diagnosis. The data are reported as a supplement to HIV diagnoses [67]. 
4.2.1.6. The Survey of Prevalent HIV Infections Diagnosed (SOPHID) 
SOPHID is a cross-sectional survey of all individuals with diagnosed HIV infection 
who require HIV-related care within the National Health Service in England, Wales, 
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and Northern Ireland within a calendar year run by the PHE. Scottish data are 
collected separately by Health Protection Scotland, and are included in the final UK 
totals. The survey began in 1995 and is conducted twice a year in London and 
annually outside London. The primary aim is to determine the total number of HIV 
prevalent patients seen for treatment and care [67]. 
4.2.2. Selecting survey respondents 
The process involved selecting and categorising survey respondents to match the 
model structure. This began by selecting NATSAL respondents according to the 
definition of current and past MSM outlined earlier. Weights for the core sample and 
the ethnic minority boost sample were applied for all calculations. For GMSHS and 
GYM, there is no exact same set of questions as in NATSAL that can be used to 
categorise current and past MSM. I therefore assumed that GMSHS and GYM 
respondents were current MSM because the majority reported anal sex with men in the 
last year (GMSHS: 90%, GYM: 89%). 
The survey respondents aged 65 or above or with missing age data were excluded. The 
remaining was divided into two age groups: 16–34 and 35–64. Most of the subsequent 
analyses were based on the two age groups except when the size of any groups was too 
small that the overall MSM would be used instead. Table 4-1 shows the numbers of 
sampled MSM from the surveys. 
For data from HIV/AIDS surveillance systems including CD4 and SOPHID databases, 
I selected only men aged 15-64 who were reported to acquire HIV infection from sex 
between men. The large number of cases allowed us to divide the datasets by age 
groups for all data analyses. 
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Table 4-1: Number of survey respondents included for data analysis 
MSM 
NATSAL 
a
   GMSHS   GYM 
n % 
 
n % 
 
n % 
  Current MSM                 
  
Aged 16-34 101.5 65.4 
 
9,936 57.5 
 
1,894 44.2 
  
Aged 35-64 53.7 34.6 
 
7,347 42.5 
 
2,393 55.8 
  
Total 155.2 100.0 
 
17,283 100.0 
 
4,287 100.0 
 
Past MSM 
        
  
Aged 16-34 7.1 25.7 
 
- - 
 
- - 
  
Aged 35-64 20.5 74.3 
 
- - 
 
- - 
  
Total 27.6 100.0 
 
- - 
 
- - 
  All MSM   
  
          
  
Aged 16-34 108.6 59.4 
 
9,936 57.5 
 
1,894 44.2 
  
Aged 35-64 74.2 40.6 
 
7,347 42.5 
 
2,393 55.8 
  
Total 182.8 100.0 
 
17,283 100.0 
 
4,287 100.0 
NATSAL: The National Survey of Sexual Attitudes and Lifestyles 
GMSHS: The Gay Men‘s Sexual Health Survey 
GYM: The London Gym Survey 
a
 With weights for core sample and the ethnic minority boost sample 
4.2.3. Data adjustment 
In the model, the population of interest is the entire MSM population aged 15-64 in the 
UK. However, the data from GMSHS and GYM were based on convenience-sampling 
from the MSM community in London. This may introduce bias into the data by 
including MSM with characteristics that are markedly different from the general MSM 
in the UK. Such differences can be observed by comparing the GMSHS and GYM 
data to the national-based NATSAL 2000 survey that used probability-sampling on a 
household basis. Table 4-2 shows, for example, that the mean number of male sexual 
partners in the last year of GMSHS men aged less than 35 were around 22 compared 
to that of 7 from NATSAL. Adjustment was necessary to improve the 
representativeness of survey populations. The adjustment method suggested by Reidy 
and Goodreau [68] was used here. 
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Table 4-2: Weight adjustment for GMSHS and GYM data 
 
Reported   Adjusted (all weights simultaneously) 
a
 
Variable NATSAL 
 
GMSHS 
 
GYM 
 
GMSHS 
 
GYM 
 
n 
b
 % 
 
n % Weight 
 
n % Weight 
 
n % 
 
n % 
  Age of respondents 
c
                                 
  
16-24 29.4 18.9 
 
892 16.6 1.138 
 
68 5.2 3.645 
 
1,322.9 23.4 
 
318.7 23.8 
  
25-34 72.1 46.5 
 
2,763 51.5 0.902 
 
652 49.8 0.933 
 
2,626.8 46.5 
 
596.1 44.5 
  
35-44 53.7 34.6 
 
1,711 31.9 1.086 
 
590 45.0 0.769 
 
1,702.4 30.1 
 
425.3 31.7 
  
median 32 
 
32 
  
35 
  
32 
 
32 
  Number of male sexual partners in the last year 
d
                               
 
Aged 16-34 
e
 
                
  
0 17.9 17.9 
 
63 1.8 9.857 
 
- - - 
 
693.8 18.4 
 
- - 
  
1 32.4 32.4 
 
494 14.3 2.271 
 
- - - 
 
1,354.3 36.0 
 
- - 
  
2 7.4 7.4 
 
249 7.2 1.024 
 
- - - 
 
267.0 7.1 
 
- - 
  
3 12.4 12.4 
 
237 6.8 1.813 
 
- - - 
 
489.2 13.0 
 
- - 
  
4 11.0 11.0 
 
207 6.0 1.841 
 
- - - 
 
366.0 9.7 
 
- - 
  
5-9 4.3 4.3 
 
542 15.7 0.273 
 
- - - 
 
144.8 3.8 
 
- - 
  
10-14 6.2 6.2 
 
451 13.0 0.474 
 
- - - 
 
195.9 5.2 
 
- - 
  
15-19 1.2 1.2 
 
190 5.5 0.215 
 
- - - 
 
39.6 1.1 
 
- - 
  
20-29 2.1 2.1 
 
350 10.1 0.212 
 
- - - 
 
63.8 1.7 
 
- - 
  
30-49 0.5 0.5 
 
271 7.8 0.065 
 
- - - 
 
16.1 0.4 
 
- - 
  
50+ 4.6 4.6 
 
408 11.8 0.389 
 
- - - 
 
134.6 3.6 
 
- - 
  
mean 7.30 
 
21.61 
  
 - 6.38 
 
                         - 
 
Aged 35-64 
                
  
0 9.7 18.1 
 
84 3.8 4.714 
 
- - - 
 
353.3 15.7 
 
- - 
  
1 19.8 37.0 
 
320 14.6 2.532 
 
- - - 
 
921.0 41.0 
 
- - 
  
2 5.8 10.8 
 
161 7.4 1.468 
 
- - - 
 
241.4 10.7 
 
- - 
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Reported   Adjusted (all weights simultaneously) 
a
 
Variable NATSAL 
 
GMSHS 
 
GYM 
 
GMSHS 
 
GYM 
 
n 
b
 % 
 
n % Weight 
 
n % Weight 
 
n % 
 
n % 
  
3 2.3 4.3 
 
139 6.3 0.678 
 
- - - 
 
89.6 4.0 
 
- - 
  
4 2.6 4.9 
 
106 4.8 1.008 
 
- - - 
 
113.4 5.0 
 
- - 
  
5-9 3.8 7.1 
 
282 12.9 0.552 
 
- - - 
 
158.4 7.0 
 
- - 
  
10-14 5.6 10.4 
 
284 13.0 0.802 
 
- - - 
 
221.1 9.8 
 
- - 
  
15-19 1.1 2.0 
 
92 4.2 0.475 
 
- - - 
 
38.6 1.7 
 
- - 
  
20-29 1.8 3.4 
 
254 11.6 0.289 
 
- - - 
 
69.9 3.1 
 
- - 
  
30-49 0.3 0.6 
 
164 7.5 0.086 
 
- - - 
 
13.6 0.6 
 
- - 
  
50+ 0.8 1.5 
 
304 13.9 0.105 
 
- - - 
 
28.5 1.3 
 
- - 
  
mean 4.48 
 
23.14 
  
  - 
 
4.87 
 
                         - 
  Number of UAI male sexual partners in the last year 
f
                             
  
0 30.6 34.8 
 
2,914 53.3 0.653 
 
514 45.9 0.758 
 
2,112.5 41.1 
 
449.9 40.0 
  
1 35.9 40.9 
 
1,506 27.5 1.485 
 
335 29.9 1.366 
 
2,463.8 48.0 
 
421.4 37.5 
  
2 10.2 11.6 
 
464 8.5 1.365 
 
105 9.4 1.234 
 
305.8 6.0 
 
137.6 12.2 
  
3 6.8 7.7 
 
167 3.1 2.524 
 
54 4.8 1.597 
 
177.3 3.5 
 
77.9 6.9 
  
4+ 4.4 5.0 
 
418 7.6 0.653 
 
111 9.9 0.503 
 
78.4 1.5 
 
37.2 3.3 
  
mean 1.52 
 
1.90 
  
2.13 
  
1.18 
 
1.34 
 
Time of last HIV test 
                
 
Aged 16-34 
                
  
In the last year 12.5 12.7 
 
1,184 34.7 0.365 
 
217 31.9 0.397 
 
352.5 9.4 
 
108.5 12.6 
  
More than a year ago 34.5 34.9 
 
1,147 33.6 1.039 
 
290 42.6 0.819 
 
1116.6 29.7 
 
269.8 31.3 
  
Never had an HIV test 51.8 52.4 
 
1,080 31.7 1.654 
 
173 25.4 2.059 
 
2290.7 60.9 
 
482.7 56.1 
 
Aged 35-64 
                
  
In the last year 8.5 18.9 
 
529 25.0 0.755 
 
172 24.9 0.758 
 
339.4 15.7 
 
107.1 19.7 
  
More than a year ago 11.1 24.8 
 
948 44.8 0.554 
 
355 51.4 0.483 
 
518.2 23.9 
 
136.6 25.1 
  
Never had an HIV test 25.2 56.3 
 
640 30.2 1.863 
 
164 23.7 2.373 
 
1308.5 60.4 
 
300.8 55.2 
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Reported   Adjusted (all weights simultaneously) 
a
 
Variable NATSAL 
 
GMSHS 
 
GYM 
 
GMSHS 
 
GYM 
 
n 
b
 % 
 
n % Weight 
 
n % Weight 
 
n % 
 
n % 
 
Total weights 
g
 
                
 
Aged 16-34 
                
  
Minimum - - 
 
- - 0.014 
 
- - 0.187 
 
- - 
 
- - 
  
Maximum - - 
 
- - 18.558 
 
- - 11.984 
 
- - 
 
- - 
 
Aged 35-64 
                
  
Minimum - - 
 
- - 0.031 
 
- - 0.187 
 
- - 
 
- - 
  
Maximum - - 
 
- - 9.537 
 
- - 3.243 
 
- - 
 
- - 
NATSAL: The National Survey of Sexual Attitudes and Lifestyles 
GMSHS: The Gay Men‘s Sexual Health Survey 
GYM: The London Gym Survey 
UAI: Unprotected anal intercourse 
Weight adjustment according to four variables: age of survey respondents, number of male sexual partners in the last year, number of UAI male sexual partners in the last year, and 
time of last HIV test. Proportions of some variables shown here may not sum to one due to rounding off decimals. 
NATSAL data of the year 2000 
GMSHS data of the year 1999, 2000, and 2001  
GYM data of the year 2000 and 2001  
a
 Adjustment with all weights simultaneously results in similar but non-identical proportions to NATSAL. 
b
 The reported numbers may not be an integer due to the original NATSAL weighting. 
c
 Age range in NATSAL is 16-44. Therefore, the age of GMSHS and GYM respondents were adjusted only of the same range. The remaining ages were left as reported. 
d
 The number of male sexual partners in the last year is not available in GYM. 
e
 The reported numbers and proportions of NATSAL for this variable are shown identical due to rounding off decimals. 
f
 The variable was not categorised by age group due to the small number of NATSAL cases. 
g
 Total weights are the product of all independent weights of the above four variables. The minimum and maximum rows represent the minimum and maximum total weight for the 
corresponding age groups, respectively. The total weights were then used for adjusting the original GMSHS and GYM data.
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To adjust the GMSHS and GYM data, I selected only the surveys that were conducted 
during 1999–2001 which corresponded to the data collection timeframe of NATSAL. 
The data were then adjusted according to four variables: (1) age of respondent, (2) the 
number of male sexual partners in the last year, (3) the number of unprotected anal 
intercourse male partners in the last year, and (4) time of last HIV test. I calculated a 
probability weight for each GMSHS and GYM respondent independently by each of 
the four variables. The weight was calculated as: 
        
,
,
,
i a
i a
i a
p
w
k
              (74) 
where 
,i aw  is the weight for respondents that fall into group i of the adjusted variable 
a, whereas 
,i ap  and ,i ak  are the proportions of respondents from the reference dataset 
(NATSAL) and the adjusted dataset (GMSHS or GYM), respectively. 
By applying the weights independently to each variable, the distribution of adjusted 
proportions of GMSHS and GYM respondents for the variable will be identical to that 
of NATSAL. Applying all weights simultaneously somewhat distorted the distribution 
of all variables (Table 4-2). The problem can be avoided by replacing the marginal 
distribution of each variable in equation (74) with the joint distribution of all four 
variables. However, the small sample size of MSM in NATSAL prevented us from 
properly deriving such joint distributions and thus the marginal distributions were used 
instead. 
The weights were then applied to GMSHS and GYM data of all years that were used 
in this study. Consequently, all model parameter values derived from these datasets 
were affected by the adjustment. The total weights range from 0.014 to 18.558 for 
GMSHS and from 0.187 to 11.984 for GYM data. I conducted an analysis to see the 
effects of introducing weight limits on the derived repeat sexual partnership formation 
rates (Figure 4-1). To maintain the accuracy of the derived model parameters, the full 
weights were used. 
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Figure 4-1: Comparison of repeat sexual partnership formation rates using 
different adjustment weights 
Each line illustrates changes in repeat sexual partnership formation rates per year of the corresponding 
classes for different adjustment weights ranging from no weight at all to full weight. The full weights 
were used in this study. 
4.3. Model parameterisation 
The model parameters can be stratified into five categories: demographics, sexual 
behaviour parameters, biological parameters, HIV diagnosis parameters, and model 
initial conditions. All parameters were initially derived using either the data from 
surveys, surveillance systems, reports, or the literature. 
4.3.1. Demographics 
According to the demographic structure of the modelled population, the estimates of 
the UK MSM population size, rate of ageing, population growth rate, and mortality 
rate by age groups were required. 
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4.3.1.1. MSM population size 
The data from the UK Office of National Statistics (ONS) and NATSAL were used to 
obtain estimates of MSM population size in the UK in 2000, the initial time point in 
the model. First, I calculated the proportions of MSM to all male respondents in 
NATSAL by regions and found that London had the highest proportion of MSM 
(6.3%) compared to elsewhere in England (2.5%), and outside England (1.7%). Since 
the age of the modelled populations (15-64) and NATSAL respondents (16-44) did not 
match, I derived the proportion of UK male population aged 45-64 to aged 40-44 from 
the 1999–2001 ONS data [69] and assumed the same proportion for UK MSM. For 
MSM aged 15, I simply assumed that the proportion of MSM in males aged 15-34 was 
the same as that of aged 16-34. The proportions of MSM by age groups and regions 
can now be obtained. The analysis also provided an estimated 5-year-interval age 
distribution of MSM aged 15-64 (Table 4-3) which will be used later for calculating 
the mortality rates (section 4.3.1.4). 
Table 4-3: Estimated 5-year age distribution of MSM aged 15-64 of year 2000 
Age group Proportion (%) 
a
 
15-19 3.13 
20-24 7.57 
25-29 10.45 
30-34 17.08 
35-39 15.63 
40-44 10.48 
45-49 9.64 
50-54 10.31 
55-59 8.38 
60-64 7.33 
Total 100.00 
a
 Estimated from NATSAL and ONS data 
 
Combining all these estimated proportions provided the proportion of MSM aged 15-
64 to the male population with the overall mean of 2.9% regardless of age groups and 
regions. However, the PHE estimated that 3.4% of all UK males are MSM [70]. I 
therefore adjusted the age group- and region-specific proportions of MSM derived 
above so that the total number of MSM accounted for 3.4% (not 2.9%) of male 
population in the UK. The adjusted proportions were then multiplied by the ONS mid-
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year population estimates and yielded 648,500 MSM (aged 15-34: 259,500, aged 35-
64: 389,000) living in the UK in 2000. Of these and according to the proportions of 
current and past MSM derived from NATSAL, there were 527,800 current MSM 
(aged 15-34: 242,678, aged 35-64: 285,122) and 120,700 past MSM (aged 15-34: 
16,822, aged 35-64: 103,878). The data used for estimating the MSM size are 
summarised in Table 4-4 and the derived parameter values are shown in Table 4-5. 
The proportion of past MSM was also used to model the flow from current to past 
MSM (Table 4-5). 
Table 4-4: Data used for deriving MSM population size in the UK of year 2000 
  Description London 
Elsewhere in 
England 
Outside 
England 
Entire UK 
  
Adjusted proportion of MSM to 
male population (%) 
a,b
 
        
  
Aged 15-34 6.60 2.67 2.78 - 
  
Aged 35-64 8.55 3.26 0.94 - 
 
Mid-year estimates size of male 
population size 
b,c
     
  
Aged 15-34 1,196,000 5,436,300 1,266,400 - 
  
Aged 35-64 1,263,000 8,087,000 1,824,800 - 
 
Proportion of current MSM (%) 
d,e
 
    
  
Aged 15-34 - - - 93.38 
  
Aged 35-64 - - - 72.42 
 
Proportion of past MSM (%) 
d,e
 
    
  
Aged 15-34 - - - 6.62 
  
Aged 35-64 - - - 27.58 
a
 Data from NATSAL and PHE 
b
 Data for the entire UK are not shown because they would result in total number of MSM population 
that are different from the current calculation which based on the three regions. 
c
 Data from ONS
 
d
 Data from NATSAL 
e
 The proportions were not stratified by regions because of the small number of cases. 
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Table 4-5: Demographic parameters 
  
Parameter Symbol 
Value 
Source 
  Aged 15-34 Aged 35-64 
 
MSM size of year 2000 
    
  
Current MSM - 242,678 285,122 NATSAL, ONS 
  
Past MSM - 16,822 103,878 NATSAL, ONS 
  
All MSM - 259,500 389,000 NATSAL, ONS 
 
Proportion of past MSM - 0.0662 0.2758 NATSAL 
 
Ageing rate per year a  0.0523 0.0261 NATSAL, ONS 
 
Growth rate per year g  0.0043 0.0056 NATSAL, ONS 
 
Mortality rate per year 
    
  
HIV-negative MSM   0.00094 0.00449 NATSAL, ONS 
    HIV-positive MSM   0.00843 0.00899 Assumed a 
a
 Assumed based on findings from ref [71] 
4.3.1.2. Rate of ageing 
The annual ageing rate equals the proportion of individuals at the maximum age in 
each age group. Since the age distribution of UK MSM populations was not available, 
I assumed that of the UK male population instead. The 2000–2020 estimated 
proportions of men aged 34 and 64 to all men aged 15-34 and 35-64, respectively, 
were obtained from the ONS projections [72]. The average proportions over the entire 
simulation period were 5.23% and 2.61% for younger and older groups (Table 4-5). 
These proportions were held constant at all time throughout model simulations. 
4.3.1.3. Population growth rate 
I assumed that size of the two age groups changes over time at the same rate as the 
general UK male populations of the same age group. The growth rate was derived by 
averaging the annual growth rates of men over 2000–2020. The average rate was 
estimated at 0.51% per year for all MSM populations (Table 4-5). The estimated 
growth rate of the younger age group (0.43%) was used for calculating the influx into 
the model of new MSM, while the rate of the older age group (0.56%) was used for 
validating the size of the modelled populations over time (see Chapter 5 for details). 
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4.3.1.4. Mortality rate 
The mortality rates for HIV-negative MSM were derived based on the mortality rates 
of the overall UK males. Age-specific data were obtained from the historic interim life 
tables for three periods (1999–2001, 2002–2004, and 2005–2007) reported by ONS 
[73]. The data were averaged over the three periods and converted into 5-year age-
specific mortality rates to match the previously defined age distribution of MSM 
(Table 4-3). Multiplying the age distribution with the mortality rates of the 
corresponding age group provided the rate by 5-year age band which were then 
collapsed into the two age groups using an arithmetic mean (Table 4-5). 
For HIV-positive men, a study by UK Collaborative HIV Cohort [71] estimated that, 
depending on various factors, the mortality rates could increase from less than 1.1 to 
nearly 10 times due to HIV. The effect is more pronounced for younger age groups 
(age 20-44) compared to the overall. Based on this information, I arbitrarily assumed 
that the death rates in the first and second age group increased by 9 and 2 times, 
respectively (Table 4-5), which applied only to treated MSM in the model since the 
majority of deaths in HIV-positive MSM in the UK occurred after they have been 
diagnosed and treated with antiretroviral treatment (ART) in late disease stages [2,70]. 
Table 4-5 summarises all derived demographic parameter values. 
4.3.2. Sexual behaviour 
The three main sources of data for deriving sexual behaviour parameters were 
NATASL, GMSHS, and GYM survey. Although the national-based probability-
sampling NATSAL survey was the primary source, I were unable to derive all 
parameters based on this survey alone due to the small sample size of MSM and lack 
of some required information. GMSHS and GYM were used when needed. Most 
sexual behaviour parameters were stratified by age and sexual activity levels 
simultaneously unless stated otherwise. Uncertainty ranges of parameters that later 
fitted to the data were also derived. 
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4.3.2.1. Sexual activity level 
Before deriving sexual behavioural parameters, survey respondents were stratified into 
two activity groups—low and high—according to the reported number of male sexual 
partners in the last year. The risk groups were defined based on three conditions. First, 
the low-activity men have a similar rate of partner change to the average of UK 
heterosexual male [57] which helped distinguish MSM with normal risk from the 
whole MSM population. Second, MSM in the low-activity group have no more than 
one sexual partner at a time. This was to ensure that a low-activity individual can 
never get infected from having a concurrent relationship. Third, the proportion of any 
risk groups must be greater than 25% because modelling sexual mixing between two 
groups that differ greatly in size could be problematic. The number of individuals in 
the smaller group may be insufficient to satisfy the demand for sexual partners from 
within and outside the group. Consequently, one male sexual partner in the last year 
was chosen as a cut-off point: low-activity MSM reported one or no male partner in 
the last year, high-activity MSM reported two or more male partners in the last year. 
Observations with missing values for the variable were removed from the 
stratification, and excluded from any further calculations that must be stratified by 
sexual activity level. Information on the number of male sexual partners in the last 
year was not available from GYM. Instead, I used the reported number of male anal-
sexual partners in the past 12 months and stratified GYM participants using the same 
cut-off point. The numbers of MSM by sexual activity level are shown in Table 4-6. 
Table 4-6: Number of MSM stratified by sexual activity level 
  MSM Aged 16-34 % Aged 35-64 % Total % 
  NATSAL             
  
Low 50.3 50.3 29.4 55.1 79.7 52.0 
  
High 49.7 49.7 24.0 44.9 73.7 48.0 
    Total 100.0 100.0 53.4 100.0 153.4 100.0 
  GMSHS 
      
  
Low 4943.9 54.1 3692.1 56.8 8636 55.2 
  
High 4195.4 45.9 2809.4 43.2 7004.8 44.8 
    Total 9139.3 100.0 6501.5 100.0 15640.8 100.0 
  GYM 
      
  
Low 608.7 29.9 607.0 35.9 1215.7 32.6 
  
High 1425.7 70.1 1084.6 64.1 2510.3 67.4 
    Total 2034.4 100.0 1691.6 100.0 3726.0 100.0 
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Table 4-7: Sexual behaviour parameters 
 
Parameter Symbol 
Value 
Source 
 
Aged 15-34 
 
Aged 35-64 
 
Low-activity High-activity 
 
Low-activity High-activity 
 
Repeat sexual partnership 
       
 
Rate of repeat sexual partnership formation per year 
rep
  
0.422 
(0.405-0.438) 
3.135 
(2.761-3.509)  
0.458 
(0.438-0.478) 
2.719 
(2.445-2.994) 
GMSHS 
 
Gap length between two consecutive repeat sexual partnerships (days) G  178 33  
178 33 NATSAL 
 
Rate of repeat sexual partnership dissolution per year   0.530 4.372 
 
0.590 3.604 Calculated 
 
Proportion of repeat sexual partnerships that involve anal sex to all repeat 
sexual partnerships 
rep
anal
p  
0.958 
(0.948-0.969) 
0.706 
(0.690-0.723)  
0.879 
(0.859-0.899) 
0.643 
(0.620-0.665) 
GMSHS 
 
Proportion of repeat sexual partnerships that involve oral sex to all repeat 
sexual partnerships 
1
rep
anal
p  0.042 0.294 
 
0.121 0.357 GMSHS 
 
Proportion of susceptibles who have UAI with a perceived HIV negative 
repeat sexual partner 
a
 ,
rep
uai pneg
p  0.369-0.657 0.328-0.556 
 
0.288-0.548 0.231-0.426 GYM 
 
Proportion of susceptibles who have UAI with a diagnosed HIV positive 
repeat sexual partner 
b
 ,
rep
uai dpos
p  0.194-0.601 0.041-0.144 
 
0-0.267 0-0.111 GYM 
 
Frequency of sexual acts with a repeat sexual partner per week   1.49-3.56 1.49-3.56 
 
1.03-2.03 1.03-2.03 NATSAL 
 
Proportion of UAI acts to all sex acts in UAI repeat sexual partnership - 1.00 1.00 
 
1.00 1.00 Assumed 
 
Effects of HIV diagnosis on the proportion of UAI acts - 0.3 0.3 
 
0.3 0.3 [74] 
 
One-off sexual partnership 
       
 
Rate of one-off sexual partnership formation per year 
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Parameter Symbol 
Value 
Source 
 
Aged 15-34 
 
Aged 35-64 
 
Low-activity High-activity 
 
Low-activity High-activity 
  
MSM without a repeat sexual partner 
one
Y
  
0.255 
(0.218-0.291) 
10.019 
(6.235-13.803)  
0.390 
(0.342-0.438) 
9.260 
(6.343-12.178) 
GMSHS 
  
MSM with a repeat sexual partner 
one
P
  - 
8.960 
(7.675-10.246)  
- 
8.219 
(6.841-9.596) 
GMSHS 
 
Proportion of one-off sexual partnerships that involve anal sex to all one-off 
sexual partnerships        
  
MSM without a repeat sexual partner 
,
one
anal Y
p  0.905 0.607 
 
0.769 0.495 GMSHS 
  
MSM with a repeat sexual partner 
,
one
anal P
p  - 0.547 
 
- 0.518 GMSHS 
 
Proportion of one-off sexual partnerships that involve oral sex to all one-off 
sexual partnerships        
  
MSM without a repeat sexual partner 
,
1
one
anal Y
p  0.095 0.393 
 
0.231 0.505 GMSHS 
  
MSM with a repeat sexual partner 
,
1
one
anal P
p  - 0.453 
 
- 0.482 GMSHS 
 
Proportion of susceptibles who have no UAI with a one-off sexual partner 
(Group A)        
  
MSM without a repeat sexual partner 
,
one
A Y
p  0.321 0.477 
 
0.364 0.573 GMSHS 
  
MSM with a repeat sexual partner 
,
one
A P
p  - 0.596 
 
- 0.599 GMSHS 
 
Proportion of susceptibles who have UAI only with a perceived HIV negative 
one-off sexual partner (Group B)        
  
MSM without a repeat sexual partner 
,
one
B Y
p  0.449 0.167 
 
0.338 0.071 GMSHS 
  
MSM with a repeat sexual partner 
,
one
B P
p  - 0.184 
 
- 0.166 GMSHS 
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Parameter Symbol 
Value 
Source 
 
Aged 15-34 
 
Aged 35-64 
 
Low-activity High-activity 
 
Low-activity High-activity 
 
Proportion of susceptibles who have UAI with a diagnosed HIV positive one-
off sexual partner (Group C)        
  
MSM without a repeat sexual partner 
,
one
C Y
p  0.230 0.356 
 
0.298 0.357 GMSHS 
  
MSM with a repeat sexual partner 
,
one
C P
p  - 0.220 
 
- 0.234 GMSHS 
 
Proportion of UAI one-off sexual partners in Group B 
       
  
MSM without a repeat sexual partner 
, ,
one
uai Y B
p  1.000 0.535 
 
1.000 0.844 GMSHS 
  
MSM with a repeat sexual partner 
, ,
one
uai P B
p  - 0.695 
 
- 0.673 GMSHS 
 
Proportion of UAI one-off sexual partners in Group C 
       
  
MSM without a repeat sexual partner 
, ,
one
uai Y C
p  1.000 0.566 
 
1.000 0.624 GMSHS 
  
MSM with a repeat sexual partner 
, ,
one
uai P C
p  - 0.578 
 
- 0.559 GMSHS 
 
Sexual roles 
       
 
Proportion of insertive acts in an anal-sex partnership 
ins
p  0.5 0.5 
 
0.5 0.5 Assumed 
c
 
 
Proportion of receptive acts in an anal-sex partnership 1
ins
p  0.5 0.5 
 
0.5 0.5 Assumed 
c
 
 
Proportion of UROI acts in an oral-sex repeat sexual partnership 
ste
uroi
p  1.0 1.0 
 
1.0 1.0 Assumed 
 
Proportion of UROI acts in an oral-sex one-off sexual partnership 
cas
uroi
p  0.139 0.249 
 
0.228 0.259 GYM 
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Parameter Symbol 
Value 
Source 
 
Aged 15-34 
 
Aged 35-64 
 
Low-activity High-activity 
 
Low-activity High-activity 
 
Sexual contact mixing 
       
 
Mixing odds ratio 
       
  
By age group 
age
w  4.2 NATSAL 
  
By sexual activity level 
sex
w  3.0 [75] 
  
By HIV serostatus 
hiv
w  2.3 GYM 
NATSAL: The National Survey of Sexual Attitudes and Lifestyles 
GMSHS: The Gay Men‘s Sexual Health Survey 
GYM: The London Gym Survey 
UAI: Unprotected anal intercourse 
UROI: Unprotected receptive oral intercourse 
The values in parentheses represent the lower and upper limits of the corresponding parameters that were included in the model fitting. 
a
 Perceived HIV negative stages include stage S, U1, U2, U3, U4, and U5 
b
 Diagnosed HIV positive stages include stage D1, D2, D3, D4, D5, and T 
c
 Assumed based on findings from ref [76], GMSHS, and GYM data 
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4.3.2.2. Rate of partnership formation 
The rate of partnership formation was calculated from the reported number of male 
sexual partners in the last year categorising into repeat sexual and one-off sexual 
partners. GMSHS provided information that matched the previously defined 
definitions of partnership type (Section 3.4.4) and was hence used. The mean repeat 
sexual partnership formation rate of high-activity MSM is approximately seven times 
higher than that of the low-activity (Table 4-7). For one-off sexual partners, 
respondents were also stratified into those who are currently having a repeat sexual 
partner or not by assuming that individuals having concurrent relationships are those 
who reported both steady and casual partners in the last year. According to the 
definition of risk group, only high-activity MSM can have a one-off sexual partner 
while in a relationship with a repeat sexual partner. Both repeat sexual and one-off 
sexual partnership formation rates were included in the model fitting with the ranges 
derived from the 95% confidence interval of the GMSHS data. All derived rates are 
summarised in Table 4-7. 
4.3.2.3. Rate of repeat sexual partnership dissolution 
This began by finding the gap duration between two consecutive non-concurrent 
repeat sexual partnerships. NATSAL provided date (in month) of the first and last sex 
acts for the three most recent partners. Gap length was defined as time between the 
first sex act with the most or second most recent partner and the last sex act with the 
second or third most recent partner, respectively. A gap length of 15 days was 
assumed for those who reported the same month for the end of last relationship and the 
start of new relationship. I excluded any concurrent relationships from the calculation 
and derived the median gap duration by sexual activity level only due to the small 
number of cases. The results suggested that, after pair separation, low-activity MSM 
tend to stay single for a much longer period than the high-activity MSM before 
acquiring a new repeat sexual partner (Table 4-7). 
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With the above gap lengths, I calculated the mean duration of repeat sexual 
partnership as follows: 
        
1
G

              (75) 
where   is the repeat sexual partnership formation rate and G  is the gap length. The 
rate of repeat sexual partnership dissolution was then derived from the inverse of 
repeat sexual partnership duration. The results are shown in Table 4-7. 
4.3.2.4. Proportion of anal-sex and oral-sex partnerships 
In order to model HIV infection via oral and anal sex separately, the model required 
the proportions of repeat sexual and one-off sexual partnership that involves anal 
sexual intercourse. This was estimated from GMSHS data by dividing the number of 
male anal-sexual partners by the total number of male sexual partners in the last year 
of the same partnership type. Table 4-7 shows the point and 95% CI estimates of the 
mean proportions of anal-sex repeat sexual partnership of around 90% for low-activity 
and 70% for high-activity MSM. This seems plausible since the high-activity MSM 
are able to have an anal-sex relationship with a one-off sexual partner while in a repeat 
sexual relationship. 
Based on the assumption that all sexual intercourses in non-anal sex relationships were 
oral sex, subtracting the anal-sex proportion from one resulted in the proportion of 
oral-sex partnerships (Table 4-7). All oral sexual intercourses that might occur in an 
anal-sex partnership were ignored because the risk of HIV transmission through oral 
sex is much less than that of anal sex [33]. 
4.3.2.5. Unprotected sexual intercourse 
There are a number of parameters related to unprotected anal intercourse (UAI) 
including proportion of UAI acts, proportion of susceptibles who perform UAI acts, 
and proportion of sexual roles—insertive and receptive act. All must be distinguished 
between repeat sexual and one-off sexual partnerships. For repeat sexual partnerships, 
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the first two parameters are the proportion of susceptibles who have UAI with a 
perceived HIV negative repeat sexual partner to all susceptibles who have a perceived 
HIV negative repeat sexual partner, and the proportion of susceptibles who have UAI 
with a diagnosed HIV positive repeat sexual partner to all susceptibles who have a 
diagnosed HIV positive repeat sexual partner. The perceived HIV negative partner 
included all those partners that have never been diagnosed with HIV. Data were 
available in the GYM survey. I selected only respondents who reported anal sex in the 
past 12 months and disclosed the perceived serostatus of their repeat sexual partner. 
Since this is the proportion of susceptibles only, those who tested HIV positive were 
excluded. Although some of the selected respondents may have been infected with 
HIV but were unaware of the infection, this was unlikely to add bias to the data since 
their sexual behaviour should remain unchanged. The mean estimates of the 
proportion were derived from dividing the number of respondents who reported UAI 
with perceived HIV negative regular partners in the past 3 months by the total number 
of those who had perceived HIV negative regular partners (Table 4-7). The same 
method was applied to a repeat sexual partner of diagnosed HIV positive status. The 
inconsistency in the definitions of sexual partner used in the GYM survey (survey-
participant-defined regular partner) and this study (repeat sexual partner) may result in 
an increased uncertainty of the derived parameters. Subsequently, I arbitrarily 
expanded the derived lower limit of both parameters by 30% due to the fact that UAI 
should be less likely in a relationship that is more casual which is a part of the repeat 
sexual partnership. These two parameters were later assigned the uniform distribution 
and included in parameterisation by model fitting. Details are shown in the next 
chapter. 
I further assumed that, in a pair of repeat sexual partners between susceptibles and 
undiagnosed MSM with UAI, all sex acts are UAI of which 50% were insertive acts. 
This was supported by GMSHS and GYM data that suggested that, on average, MSM 
across age group and sexual activity level performed versatile sexual roles with their 
regular partner. For a pair between susceptibles and diagnosed MSM, the proportion of 
UAI acts was reduced by 70% according to the findings from the meta-analysis study 
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of high-activity sexual behaviour in HIV-positive individuals in the United States [74]. 
The reduction in UAI acts was then added to safe sex to maintain the constant number 
of acts across all groups and time period. See Table 4-7 for summary of the parameter 
values. 
For one-off sexual partnerships, susceptibles were categorised into: A) MSM who had 
no UAI with a one-off sexual partner, B) MSM who had UAI only with a perceived 
HIV negative one-off sexual partner, and C) MSM who had UAI with a diagnosed 
HIV positive one-off sexual partner. The proportions for these three groups were 
estimated using GMSHS data. This started from dividing perceived HIV negative 
respondents into those who had or had no UAI with a one-off sexual partner. The 
number of MSM without UAI was used for calculating the proportion of group A. For 
those who reported UAI with a one-off sexual partner, if the reported number of 
perceived HIV negative UAI one-off sexual partners was equal to the total number of 
UAI one-off sexual partners, they were included in group B. And group C 
corresponded to those who had at least one HIV-positive one-off sexual partner. I 
divided all groups by their sum to obtain estimates of the proportions of men in each 
group (Table 4-7). Similarly to one-off sexual partnership formation rate, the estimates 
were calculated separately for men who had and had no repeat sexual partners in the 
last year. 
In group B and C, the proportion of UAI was derived from the mean proportion of 
reported number of UAI one-off sexual partners to all one-off sexual partners in the 
last year. For group B, perceived HIV negative partner is from susceptible or 
undiagnosed HIV-infected stages only. For group C, I assumed chance of choosing 
one-off sexual partners of any HIV stages is proportional to the number of individuals 
in each stage. 
Similarly to the repeat sexual partnership, I assumed 50% for insertive and receptive 
act for both safe and unsafe sex with a one-off sexual partner of all classes. Although, 
studies among MSM in Australia [77] and the United States [78] suggested that in an 
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unprotected anal intercourse with an HIV positive partner, MSM were more likely to 
perform insertive rather than receptive acts, while receptive acts were performed more 
frequently with a perceived HIV negative partner, this was not evident in the UK [76]. 
Given that the sexual act is one-off, assuming the proportion of sexual roles based 
either on the number of partners or the number of acts makes no differences. 
Regarding oral sex, UROI with ejaculation was assumed the only type of oral 
intercourse that presents a risk of transmitting HIV. I further assumed UROI occurs in 
all sex acts with an oral-sex repeat sexual partner (Table 4-7). This may seem an 
extreme case, but its effect is considered minor since the HIV transmission probability 
of UROI is substantially lower than that of anal sex [33]. For one-off oral sex, I 
derived the proportion of UROI from the number of GYM men who reported UROI 
with a one-off sexual partner (Table 4-7). For simplicity, modelling HIV spread via 
one-off oral sex was carried out without categorising MSM into three groups based on 
serostatus of partner as previously did for the anal sex. 
4.3.2.6. Frequency of sexual acts 
The mean numbers of sex acts per week with a repeat sexual partner were estimated 
through the model fitting. I started by obtaining the plausible ranges of the parameter 
values from the number of occasions of sex with men in the last 4 weeks reported in 
NATSAL. I selected only the respondents who, in the last 4 weeks, had only one male 
partner of any types. Due to a small number of eligible cases, the derived estimates 
could only be stratified by age groups which led to identical ranges for both sexual 
activity levels in the same age groups. The sampling distribution of the parameter in 
the fitting process was assumed uniform and the sampled values were allowed to vary 
independently by both age groups and sexual activity levels. Table 4-7 summarises the 
derived estimates. 
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4.3.2.7. Sexual mixing preference 
In this model, mixing preferences were stratified by age group, sexual activity level, 
and perceived HIV serostatus. All are modelled using the odds ratio in a 2-by-2 
mixing matrix [48,60]. 
NATSAL included information on mixing by age. However, the age cut-off point must 
be adjusted specifically for this calculation due to the small number of cases. 
Therefore, a median age of 28 was used as a new cut-off point for age stratification. 
To construct a mixing matrix by age, respondents were divided by their age and the 
age of their most recent partner on the first sex. For the younger group (under 28 years 
of age), 72% selected a partner in the same age group, while only 37% of the older 
group (28 years of age or more) did that. The corresponding odds ratio was 4.2 (Table 
4-7) which indicated that MSM are 4.2 times more likely to choose a partner of the 
same age group than when choosing randomly (a proportionate mixing). 
With insufficient data available to inform the mixing preference by sexual activity 
level of MSM in the UK, I adopted the estimated odds ratio of 3.0 of male 
heterosexuals in London [79] (Table 4-7). 
The perceived HIV serostatus was divided into perceived HIV negative and diagnosed 
HIV positive status. The perceived negative status included non-infected and 
undiagnosed HIV-infected MSM. The diagnosed positive status included all MSM 
with diagnosed HIV. From the reported HIV status of GYM men and their regular 
partner, the odds ratio of 2.3 was estimated (Table 4-7). Mixing by the perceived HIV 
serostatus using odds ratio was only applied to a repeat sexual partner selection. A 
different method was used to model the effects of one-off sexual partner‘s serostatus 
and the proportion of UAI (serosorting). See Section 3.5.10 for more details of the 
method. 
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4.3.3. HIV transmission probability 
To estimate the per-sex act probability of HIV transmission among MSM, sex acts 
were categorised according to the sexual types and roles existing in the model—
insertive and receptive anal sex, and receptive oral sex. Each of these was divided into 
protected and unprotected acts according to condom use. Changes in HIV transmission 
due to disease progression on the basis of CD4 cell counts were included. The very 
low, but non-zero, HIV transmission probabilities of ART-treated MSM were 
calculated separately and allowed to change over time to reflect an increase in ART 
effectiveness on infectiousness reduction and improved drug adherence among HIV-
infected patients. The main calculation steps were calculating the relative risks of HIV 
infection of the viral load of interest to the baseline viral load. The derived relative 
risks were then applied to the baseline transmission probability obtained from 
literature review to estimate the infectiousness according to viral load. Finally, the 
proportion of men by viral load in each CD4 stage was multiplied to the above 
transmission probability to provide the final per-act HIV transmission probability. 
I started by analysing the viral load data from the survey of diagnosed HIV-infected 
MSM seen for HIV-related care at clinics in the UK [67] from 2005 to 2009. Only 
individuals who have never been treated with ART were selected and their reported 
viral load at that clinic visit was divided into five ranges: 0-399, 400-999, 1000-9999, 
10000-49999, and 50000+ copies/mL of blood plasma, and the CD4 counts at the 
same visit into four ranges: <200, 200-349, 350-499, and ≥500 cells/µL. If there were 
more than one record of viral load in each CD4 stage, only the latest one available was 
used. The proportions of men by viral load ranges in each CD4 stage were then 
calculated (Table 4-8). It is clearly seen that in the lower CD4 stages, the proportion of 
men with high viral load is markedly higher than in higher CD4 stages. For example, 
55% of MSM with CD4<200 cells/µL had viral load of 50000+ copies/mL while there 
were only 23% among MSM with CD4≥500 cells/µL. The uncertainty in these 
proportions were taken into account by running 10,000 simulations for each CD4 stage 
based on multinomial distribution with the number of cases parameter equals to the 
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number of included SOPHID respondents and the event probability parameter equals 
the average proportions. I then derived a median viral load to represent the five viral 
load ranges (Table 4-8). The CD4 stratification was neglected at this point because the 
minor effects it had on the derived median estimates. 
Table 4-8: Data used for calculating HIV transmission probability of MSM who 
have never been treated with antiretroviral treatment 
  
Description 
Viral load (copies/mL) 
  0- 399 400-999 1,000-9,999 10,000-49,999 50,000+  
 
Median viral load (copies /mL) 
a
 49 1,690 6,234 22,948 102,077 
                
 
Proportion of men by viral load in 
each CD4 stage 
a
      
  
CD4 ≥ 500 0.1051 0.1700 0.1763 0.3219 0.2267 
  
CD4 350-499 0.0700 0.1133 0.1487 0.3552 0.3129 
  
CD4 200-349 0.0830 0.0840 0.1168 0.3341 0.3821 
  
CD4 < 200 0.1085 0.0814 0.0492 0.2136 0.5475 
                
 
HIV transmission probability (%) 
b
 
     
  
URAI 
0.135 
(0.019-0.241) 
0.535 
(0.076-0.956) 
0.889 
(0.127-1.588) 
1.477 
(0.211-2.637) 
2.640 
(0.377-4.714) 
  
UIAI 
0.060 
(0.007-0.162) 
0.237 
(0.027-0.642) 
0.394 
(0.044-1.067) 
0.654 
(0.074-1.772) 
1.169 
(0.132-3.168) 
  
UROI 
0.004 
(0.001-0.016) 
0.015 
(0.004-0.065) 
0.025 
(0.006-0.108) 
0.042 
(0.011-0.179) 
0.075 
(0.019-0.321) 
URAI: Unprotected receptive anal intercourse 
UIAI: Unprotected insertive anal intercourse 
UROI: Unprotected receptive oral intercourse 
The values in parentheses represent the lower and upper limits of the corresponding parameters that 
were included in the model fitting. 
a
 Estimated from SOPHID 2005–2009 data 
b
 Not the final transmission probability 
The baseline transmission probabilities per an unprotected receptive anal intercourse 
(URAI) act of 1.4% (0.2-2.5) suggested by Baggaley et al based on systematic review 
and meta-analysis were used [80]. For an unprotected insertive anal intercourse (UIAI) 
act, the estimates of 0.62% (0.07-1.68) from the cohort study among homosexual men 
in Sydney was adopted [81]. I used per an unprotected receptive oral intercourse 
(UROI) contact risk of 0.04% (0.01-0.017) suggested by Vittinghoff et al [33]. The 
viral load associated with the above baseline transmission probabilities was assumed 
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20,000 copies/mL which was derived from the median viral load of the survey 
participants who have never been on ART. 
I then described the relationship between transmission probability and plasma viral 
load according to the function proposed by Smith & Blower [82], following the 
original notations, as: 
      10
log ( / )
( ) 2.45 ( )
v w
v w              (76) 
where w  is the initial viral load which, in this case, is the viral load of the baseline 
transmission probability, v  is the viral load of interest, ( )v  
and ( )w  are 
transmission probability at the corresponding viral load v  and w . The lower and 
upper bound were derived from the corresponding limits of the baseline per-act 
transmission probability (Table 4-8). Based on these boundaries, I sampled from the 
beta distribution and produced 10,000 sets of per-act transmission probability by viral 
load for each CD4 stage. Multiplying these 10,000 samples with the previously 
sampled proportion of individuals by viral load in each CD4 stage, I obtained the 
combined sets of simulation results which were then used for deriving the median and 
2.5
th
 and 97.5
th
 percentiles as lower and upper estimates of the final per-act 
transmission probabilities. The infectiousness of primary HIV infection (PHI) was 
estimated by applying a relative risk of 9.17, suggested by Boily et al [83], to the 
baseline transmission probabilities. All derived estimates are summarised in Table 4-9. 
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Table 4-9: Estimated per-act HIV transmission probability 
 
HIV transmission 
probability (%) 
Type of sexual act 
 
URAI Symbol UIAI Symbol UROI Symbol 
 
ART-naïve MSM 
 
 
 
 
 
 
  
PHI 
12.838 
(1.834-22.925) ,2 ,3
,
urai urai
   
5.685 
(0.642-15.406) ,2 ,3
,
uiai uiai
   0.367 
,2 ,3
,
uroi uroi
   
  
CD4 ≥ 500 
1.336 
(0.191-2.386) ,4 ,5
,
urai urai
   
0.592 
(0.067-1.603) ,4 ,5
,
uiai uiai
   0.038 
,4 ,5
,
uroi uroi
   
  
CD4 350-499 
1.553 
(0.222-2.773) ,6 ,7
,
urai urai
   
0.688 
(0.078-1.863) ,6 ,7
,
uiai uiai
   0.044 
,6 ,7
,
uroi uroi
   
  
CD4 200-349 
1.662 
(0.237-2.968) ,8 ,9
,
urai urai
   
0.736 
(0.083-1.995) ,8 ,9
,
uiai uiai
   0.047 
,8 ,9
,
uroi uroi
   
  
CD4 < 200 
1.863 
(0.266-3.326) ,10 ,11
,
urai urai
   
0.825 
(0.093-2.235) ,10 ,11
,
uiai uiai
   0.053 
,10 ,11
,
uroi uroi
   
 
ART-treated MSM 
 
 
 
 
 
  
  
Before 2005 
0.363 
(0.229-0.558) ,12urai
  
0.158 
(0.072-0.303) ,12uiai
  0.009 
,12uroi
  
  
Changes per 
year during 
2005–2009 a 
-0.039 - -0.016 - -0.001 - 
URAI: Unprotected receptive anal intercourse 
UIAI: Unprotected insertive anal intercourse 
UROI: Unprotected receptive oral intercourse 
PHI: Primary HIV infection 
The values in parentheses represent the lower and upper limits of the corresponding parameters that 
were included in the model fitting. 
a
 HIV transmission probability after 2009 was assumed equal to that of 2009. 
For HIV transmission probability of ART-treated MSM, only MSM in the UK who 
have ever been treated with ART were included in the calculation. A decrease over 
time in the derived per-act transmission probabilities was incorporated into the model. 
To achieve that, I fitted a linear function to the proportions of MSM by viral load, 
CD4 stages, and calendar year simultaneously and estimated an average changes over 
2005–2009 in these proportions. The proportions before 2005 was assumed equal to 
that of 2005, and for the period after 2009 the same probabilities as of 2009 was 
assumed. The rest of the calculations were carried out in the same manner to that of 
ART-naïve MSM. I derived annual change rate in transmission probabilities by 
subtracting the linear estimates of the any calendar year by estimates of the immediate 
previous year. In the fitting process (Chapter 5), a lowest ART transmission 
probability of 0.001% was set for all types of sex acts to prevent the zero or negative 
values. The derived probabilities of transmitting HIV from ART-treated MSM and the 
changes over time are reported in Table 4-9. 
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The effects of circumcision were not included according to a recent study that found 
no evidence to support the effects of circumcision in reducing HIV transmission risk 
among MSM in Britain [84]. I also decided not to include the effects of STIs in the 
model due to a lack of evidence to support that STIs are risk factors for HIV 
transmission among MSM [85,86]. 
The average efficacy of condom at reducing transmission of HIV among MSM was 
taken from the meta-analysis estimates of the efficacy in reducing heterosexual HIV 
transmission [87-89]. I assumed the per-act efficacy of 80% and the lower and upper 
limit of 75-95% (Table 4-10). The estimates were adopted only for anal sexual 
intercourses. No risk of HIV infection for all types of oral sex with condom use was 
assumed. 
Table 4-10: Condom efficacy in preventing HIV transmission 
 
Parameter Symbol Value 
 
Source 
 
Condom efficacy per sexual act 
cdm
  
0.80 
(0.75-0.95)  
Assumed 
a
 
The values in parentheses represent the lower and upper limits of the corresponding parameters that 
were included in the model fitting. 
a
 Assumed based on findings from ref [87-89] 
4.3.4. HIV diagnosis rate 
The rate of HIV diagnosis controls the number of MSM moving from undiagnosed to 
diagnosed stages in each time step. I defined time-dependent HIV diagnosis rates by 
assuming increasing rates over 2000–2004 according to the rise in the reported number 
of new diagnoses during that period [66]. The initial diagnosis rate as of the year 2000 
increased by a constant rate of changes until the end of 2004 and remained unchanged 
until the end of the simulation. 
The HIV diagnosis rates will be estimated through model fitting in the next chapter 
based on uninformative uniform priors. In this chapter, only the lower and upper 
estimates were derived from the reported numbers of new diagnoses by age and CD4 
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cell counts over 2000–2009. The effects of sexual activity level were also taken into 
account in this step. 
The baseline rates of diagnosis with HIV in UK MSM were calculated by dividing the 
reported number of new diagnoses by the estimates of undiagnosed HIV prevalence 
with 95% credible intervals which were available from 2001 to 2007 [54,90]. Since 
the 2000 estimates of undiagnosed prevalence were not available, the 2001 estimates 
were used which provided the baseline rates of 0.15 to 0.27 per year. According to the 
reported median CD4 at diagnosis of UK MSM of 366 cells/µL in 2001, I assumed the 
above baseline diagnosis rates for HIV-positive MSM at CD4 350-499 cells/µL in the 
model. 
I then reduced the lower and upper limits of the initial rates by 30% to account for 
three main uncertainties. First, the initial rates are likely to be lower if the 2000 
estimates of undiagnosed prevalence were made available and used. Second, the 
difference in the age ranges which were 15-59 years for the reported undiagnosed 
prevalence and 15-64 years in this model should decrease the rates. Third, it is more 
likely for HIV-positive MSM at CD4 350-499 cells/µL to have lower average 
diagnosis rates than the baseline because the median CD4 at diagnosis of UK MSM is 
almost out of the lower range of the CD4 stage. Based on the fact that the diagnosis 
rates could vary substantially across different disease stages with a very low rate 
during PHI to a much higher rate in an advanced HIV stage [91], I allowed initial 
diagnosis rates to increase by 0.05–0.15 per a CD4 stage advanced in disease 
progression. 
Data from all three behavioural surveys (NATSAL, GMSHS, and GYM) surveys 
showed that, regardless of age group, high-activity MSM tested for HIV considerably 
more frequently than low-activity men. The diagnosis rates were allowed to differ 
between low- and high-activity men according to the differences in frequency of HIV 
testing from the survey data. I analysed the reported time of the last HIV test from 
NATSAL and arbitrarily assumed that individual tests every 12 months if he reported 
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last test in the last year, 24 months for 1-2 years ago, and 60 months for 2-5 years ago. 
The rates of diagnosis were calculated as an inverse of the assumed frequencies of 
testing. Those who have tested more than 5 years ago or never had an HIV test were 
assigned a rate of zero. This resulted in an average testing rate of high-activity MSM 
that was 2.5-fold higher than that of low-activity MSM. Conducting the similar 
analysis on GMSHS and GYM data yielded estimates of 1.70 and 1.78, respectively. 
Furthermore, the analysis also suggested that this ratio tended to remain unchanged 
over time. I therefore assumed a range of 1 (no difference) through 3 for this ratio 
which, in the next step of model fitting, will be applied to the initial diagnosis rate to 
calculate diagnosis rates by sexual activity level. The derived initial diagnosis rates are 
summarised in Table 4-11. 
Table 4-11: HIV diagnosis parameters 
 
Parameter Symbol Value 
 
Initial HIV diagnosis rates per year 
a
   0.102-0.191 
 
Ratio of diagnosis rate of high-activity to low-activity MSM 
b
 - 1-3 
 
Increase in initial diagnosis rates per a CD4 stage 
c
 - 
 
0.05-0.15 
 
Changes per year in HIV diagnosis rate during 2000–2004 d   0.001-0.0339 
 
Proportion of MSM who change sexual activity group after HIV diagnosis  
 
 
    From low-activity to high-activity group 1s  
0.07 
 
    From high-activity to low-activity group 2s  
0.66 
Identical interval estimates of HIV diagnosis rate for MSM of different sexual activity level, age group, 
and disease stage were assumed. The interval estimates in this table will be used for constructing 
uniform priors used for estimating the diagnosis rates via model fitting. 
a
 At the beginning of year 2000; for MSM at CD4 350-499 cells/µL 
b
 Derived from NATSAL, GMSHS, and GYM data 
c
 An absolute increase of the corresponding rates 
d
 The lower bound was assumed 0.001 and the upper bound was derived from simulations based on 
uniform distribution. 
The change rates per year were derived by conducting 10,000 simulations and 
uniformly drew from the interval estimates of the 2001–2004 baseline diagnosis rates. 
For each simulation, subtracting the rates of all calendar year by the rates of the 
immediate previous year provided the changes of rate over time that were further used 
for calculating the average changes for the period. The 2.5
th
 and 97.5
th
 percentiles of 
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these averages were -0.014 to 0.034. According to the reported numbers of new HIV 
diagnoses in MSM in the UK [66], it is unlikely that the diagnosis rates had decreased 
in that period, and hence the negative value was replaced with a very small positive 
value (0.001) for the lower limit of the change rates. No differences by CD4 stages 
and sexual activity levels were included. The derived estimates for changes over time 
in diagnosis rates are shown in Table 4-11. 
I estimated the effects of HIV diagnosis on sexual activity level from a cohort study of 
98 UK MSM [75]. The findings suggested that around 66% of MSM reduced the 
number of casual partners in the past 12 weeks after diagnosis of PHI while only 7% 
reported more casual partners. These percentages were used as the proportions of 
MSM who change sexual activity level after HIV diagnosis (Table 4-11). 
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4.3.5. Rate of initiating HIV treatment 
The rate of diagnosed HIV-positive MSM starting an HIV treatment was taken from 
the UK Collaborative HIV Cohort (CHIC) Study [92] which provided the per 3-month 
period estimates by CD4 counts that ranged from 0.005 for CD4 350-499 cells/µL to 
0.95 for CD4<100 cells/µL. The rates were derived based upon the guidelines 
regarding time to initiate HIV treatment in the UK [59]. Starting ART at CD4≥500 
cells/µL is rather unusual; therefore, an assumption was made that the treatment 
initiation rate for MSM at CD4≥500 cells/µL is as low as 10% of those with CD4 350-
499 cells/µL. For CD4 200-349 cells/µL, I used an average derived from the rates of 
CD4 200-249, 250-299, and 300-349 cells/µL. For those with CD4<200 cells/µL, an 
average rate of CD4 0-99 and 100-199 cells/µL was used (Table 4-12). There was no 
ART initiation during PHI due to a small number of cases. 
Table 4-12: Rate of initiating HIV treatment 
 
Parameter Symbol Value 
 
Rate before 1
st
 January 2009 (per year)  
 
  
CD4 ≥ 500 
5
  0.002 
  
CD4 350-499 
7
  0.02 
  
CD4 200-349 
9
  1.80 
  
CD4 < 200 
11
  3.80 
 
Rate from 1
st
 January 2009 onwards (per year) 
a
  
 
  
CD4 ≥ 500 
5
  0.02 
  
CD4 350-499 
7
  1.80 
  
CD4 200-349 
9
  3.80 
  
CD4 < 200 
11
  3.80 
HIV treatment during primary HIV infection was omitted from the model. 
a
 Revised due to an increased ART initiation threshold [59] 
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4.3.6. Disease progression 
The disease progression rate for each CD4 stage is equal to the inverse of the mean 
duration of that stage. I adopted the estimates provided by a study [93] that fitted a 
multistate Markov model to the historical CD4 data from the CASCADE database 
[94]. The study estimated an average time spent in each CD4 stage that is equivalent to 
a total time from seroconversion to AIDS of 8.6 years [93]. For PHI, I assumed 
according to Hollingsworth et al [95] a duration of 3 months with a range from 1 to 6 
months and estimated this parameter via model fitting. All derived disease stage 
durations are shown in Table 4-13. 
Table 4-13: Duration of HIV stages 
 
Parameter Symbol Value (months) 
 
PHI to CD4 ≥ 500 
 2 3
1/ ,1 /   
2.90 
(1.24-6.00) 
 
CD4 ≥ 500 to 350-499 
 4 5
1/ ,1 /   67.27 
 
CD4 350-499 to 200-349 
 6 7
1/ ,1 /   23.92 
 
CD4 200-349 to < 200 
a
 
 8 9
1/ ,1 /   20.12 
PHI: Primary HIV infection 
The values in parentheses represent the lower and upper limits of the corresponding parameters that 
were included in the model fitting. An inverse of the above stage durations is the disease progression 
rates used in the model. 
a
 In the model, individuals remained in the stage of CD4<200 cells/µL until they are either diagnosed, 
treated with ART, or removed from the model. 
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4.3.7. Initial population size 
The initial MSM population size in the UK of the year 2000 (Section 4.3.1) was 
stratified according to various modelled subpopulations to form the initial size of each 
subgroup. Range of parameters that later fitted to the data were also derived. I began 
with stratification by HIV serostatus, HIV negative and positive. The 2000 UK annual 
HIV report [96] provided the estimated number of MSM aged 15-59 living with HIV 
in the UK at the end of 1999 of 17,200 which corresponded to the overall HIV 
prevalence of approximately 3.5%. The interval estimates were not provided so I 
selected the lower limit of 2.5% and the upper limit of 4.5% (Table 4-14). In the 
model fitting in the next chapter, these interval estimates were assigned to the low-
activity men, of which I sampled the HIV prevalence parameters independently by age 
groups from the uniform distribution.  
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Table 4-14: Data used for constructing initial numbers of MSM by subgroups 
  Description Value 
 
HIV prevalence 
a
 
 
  
Baseline estimates 
b
 0.025-0.045 
  
Multiplicative factor for high-activity group 1-2 
 
Proportion of undiagnosed HIV to all HIV-positive MSM 
 
  
Undiagnosed proportion for age group 1 0.26-0.57 
  
Undiagnosed proportion for age group 2 0.18-0.40 
  
Multiplicative factor for high-activity group 1-2 
 
Proportion distribution of diagnosed MSM by disease stage 
c
 
 
  
PHI 
 
0.01 
  
CD4 ≥ 500 0.42 
  
CD4 350-499 0.27 
  
CD4 200-349 0.21 
  
CD4 < 200 0.09 
 
Proportion distribution of undiagnosed MSM by disease stage 
c
 
 
  
PHI 
 
0.02 
(0.01-0.04) 
  
CD4 ≥ 500 
0.50 
(0.40-0.60) 
  
CD4 350-499 
0.28 
(0.18-0.38) 
  
CD4 200-349 
0.15 
(0.05-0.25) 
  
CD4 < 200 
0.05 
(0.02-0.08) 
 
Proportion of ART-treated MSM to all diagnosed MSM 0.75 
 
Proportion of past MSM to all MSM by HIV status 
 
  
Susceptibles 
 
   
Aged 15-34 0.066 
   
Aged 35-64 0.276 
  
Undiagnosed HIV 0.028 
  
Diagnosed HIV 0.025 
 
Proportion of single MSM to all current MSM by class 
e
 
 
  
Aged 15-34 
 
   
Low-activity 0.463 
   
High-activity 0.530 
  
Aged 35-64 
 
   
Low-activity 0.334 
   
High-activity 0.493 
PHI: Primary HIV infection 
The values in parentheses represent the lower and upper limits of the corresponding parameters that 
were included in the model fitting. 
a
 At the beginning of year 2000; assumed for MSM at CD4 350-499 cells/µL 
b
 Assumed for low-activity MSM in model fitting. 
c
 The sum of proportions equals one. 
d
 Single MSM are men who are currently not in a repeat sexual relationship with a man. 
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The differences in HIV prevalence by sexual actively level were accounted for by 
applying the multiplicative factors directly to the sampled prevalence parameters of 
low-activity men in the same age group to obtain the estimates of high-activity men. 
Analysing GMSHS data revealed that the prevalence in the high-activity group was 
around 1.4-fold higher than that of the low-activity. I therefore assumed the range of 1 
to 2 and uniformly sampled the multiplicative factors from this range for both age 
groups. Altogether, the initial HIV prevalence for each class could be calculated and 
used for estimating its values through model fitting. 
HIV-positive MSM were then stratified by diagnosis status. I adopted the estimates 
derived from the multi-parameter evidence synthesis method (MPES) of the 
proportion of undiagnosed MSM aged 15-44 in the UK in 2001, 0.39 (0.32-0.47) [54], 
for low-activity MSM in age group 1, and the MPES estimates of MSM aged 15-59, 
0.36 (0.29-0.44) [54], for age group 2. The lower and upper limits were expanded by 
 20% to account for the uncertainty due to inconsistencies of age range and calendar 
year between MPES estimates and the model requirements. For age group 2, both 
upper and lower limits were further reduced by 25% according to the fact that the 
proportion of undiagnosed infections was likely to be lower than the population 
average. 
Similarly to the prevalence of HIV, there was a higher undiagnosed proportion in the 
high-activity than in the low-activity group as suggested by GMSHS data. 
Consequently, I accounted for the effects of sexual activity level using multiplicative 
term that were assumed to range between 1 and 2 (Table 4-14). During the fitting 
process in the next chapter, the proportions of undiagnosed HIV in low-activity men of 
both age groups were first sampled based on uniform priors. After that I drew the 
multiplicative term for effects of sexual activity level and calculated the undiagnosed 
proportion for all classes. 
Next, the proportion of ART-treated to all diagnosed MSM was derived by dividing 
the reported number of MSM who have ever been on ART obtained from the SOPHID 
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data by the estimated number of MSM living with diagnosed HIV in 2001 [54,90]. I 
obtained an estimate of 75% of diagnosed MSM who have ever been treated with 
ART. For the remaining 25% who have never been on ART, they were split by the 
five CD4 stages based on the data from the CD4 cell counts database of patients seen 
for HIV care in the UK. At that time, the number of MSM living with diagnosed HIV 
during PHI should be minimal. Hence, only 1% of all diagnosed MSM was allocated 
to the stage of PHI. 
The distribution of undiagnosed MSM by CD4 stages was adopted from a recent study 
on HIV incidence in MSM in England and Wales [97]. The lower and upper limits 
were arbitrarily assumed according to the adopted estimates (Table 4-14). The 
proportion of MSM in the undiagnosed PHI stage was assumed to be very low (2%). 
Due to a considerable uncertainty in this parameter, it was included to the model 
fitting and sampled from the Dirichlet distribution (Chapter 5). 
Combing all the above parameters (summarised in Table 4-14) resulted in the initial 
total number of MSM fully stratified by age group, sexual activity, CD4 disease stage, 
HIV diagnosis, and ART status. I further stratified the modelled population into 
current and past MSM. NATSAL estimates of the proportion of past MSM were 
approximately 7% and 28% of all MSM in age group 1 and 2, respectively. Presanis et 
al [90] also provided estimates of the proportion of past MSM among undiagnosed and 
diagnosed HIV prevalence (Table 4-14). I combined all this information to construct 
the initial numbers of past MSM by age group and disease stage. Sex between men in 
past MSM was assumed absent and therefore stratification by sexual activity was no 
longer applied. The ratio between past and current MSM by age group and disease 
stage was captured from the initial MSM size. This ratio was used for balancing the 
numbers of current and past MSM in the model at every time step. 
Finally, among current MSM, a group of individuals who reported as currently in a 
relationship with a man based on GYM data was assigned to the ‗single‘ group while 
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the remaining men belonged to the ‗pair‘ group (Table 4-14). All calculations for the 
initial numbers of MSM were carried out in the model fitting before simulations. 
4.4. Conclusion 
The majority of model parameters have been estimated in this chapter using data from 
various sources. The remaining parameters will be estimated through model fitting at 
the beginning of the next chapter. 
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5.1. Introduction 
In this chapter, the remaining unknown parameters from the previous chapter are 
estimated through model fitting. The model is then validated against external data that 
were not used in the fitting process. The final model with complete parameter values 
will be used to investigate the current HIV epidemic in men who have sex with men 
(MSM) in the UK and address the primary research questions 1 and 2. I made 
projections on the future course of the HIV epidemic from 2014 to 2020 and 
quantified the contribution of biological and behavioural factors driving the ongoing 
transmission using the population attributable fractions (PAFs). The resulting paper 
which has been published in AIDS [61] is presented later in this chapter (section 5.5). 
5.2. Model fitting 
The model was fitted using Monte Carlo filtering method [56] to match the HIV 
epidemic in MSM in the UK during 2001–2009. This began by conducting 
preliminary one-way sensitivity analyses on all model parameters to see the effects on 
the model estimates of HIV prevalence. All parameter values were varied by  50% 
and the corresponding estimates of the overall HIV prevalence at the end of 2009 were 
compared to that of the baseline simulation. Any parameters that caused the 2009 
prevalence to change greater than 10% compared to the baseline parameters were 
included in the fitting. Table 5-1 summarises results from the preliminary sensitivity 
analysis. I manually added the one-off sexual partnership formation rates, the 
proportion of susceptibles who have unprotected anal intercourse (UAI) with a 
diagnosed HIV positive repeat sexual partner, and three key model initial conditions: 
the HIV prevalence, the proportion of undiagnosed prevalence, and the distribution of 
undiagnosed prevalence by disease stages at the beginning of 2000. The probability 
distributions assigned for all fitted parameters are summarised in Table 5-1. The other 
parameters not involved in the fitting were held constant at their baseline values. 
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Table 5-1: Model parameters included in the model fitting 
  Parameter 
Effects on 
prevalence (%) 
a
 
Distribution 
 
UIAI transmission probability 18.31 Beta 
 
URAI transmission probability 47.40 Beta 
 
Condom efficacy 35.63 Uniform 
 
Rate of repeat sexual partnership formation 19.21 Beta (low-activity) and gamma (high-activity) 
 
Rate of one-off sexual partnership formation - Beta (low-activity) and gamma (high-activity) 
 
Proportion of repeat sexual partnerships that involve anal sex to all repeat sexual partnerships 50.53 Beta 
 
Proportion of susceptibles who have UAI with a perceived HIV negative repeat sexual partner 25.10 Uniform 
 
Proportion of susceptibles who have UAI with a diagnosed HIV positive repeat sexual partner - Uniform 
 
Frequency of sexual acts with a repeat sexual partner 59.71 Uniform 
 
HIV diagnosis rate 17.06 Uniform 
 
Duration of PHI stage 31.37 Gamma 
 
Initial HIV prevalence at the beginning of 2000 - Uniform 
 
Initial proportion of undiagnosed HIV to all HIV-positive MSM at the beginning of 2000 - Uniform 
 
Initial proportion distribution of undiagnosed MSM by disease stages  - Dirichlet 
UAI : Unprotected anal intercourse 
UIAI : Unprotected insertive anal intercourse 
URAI : Unprotected receptive anal intercourse 
PHI: Primary HIV infection 
a
 The results from preliminary one-way sensitivity analysis prior to the model fitting that shows the maximum percentage changes in the model estimates of HIV prevalence at the 
end of 2009 due to ± 50% changes of the fitted parameters. 
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I then sampled 20,000 different combinations of the fitted parameters using Latin 
Hypercube sampling [98] and ran 20,000 model simulations from 2000 to 2009. Using 
Monte Carlo filtering, model outputs from each parameter set were compared against 
the 2001–2009 estimates of the reported HIV prevalence, both overall and 
undiagnosed [2,90,99]. The diagnosed prevalence had a particularly narrow reported 
range and thus was excluded from the filtering criteria. Any parameter sets that were 
unable to provide estimates within ranges of all fitting data simultaneously were 
filtered out. The interval estimates of HIV prevalence were taken directly from the 
reported ranges of MSM aged 15-59, the upper limits of which were then increased by 
15% to account for the difference in the age range. 
The filtering process reduced the number of parameter sets from 20,000 to 1,093. The 
model fit to the overall and undiagnosed HIV prevalence estimates are shown in 
Figure 5-1. The filtered parameter sets also provided an adequate fit to the diagnosed 
prevalence data judging from the resulting median estimates (Figure 5-1). The 
estimated number of MSM aged 15-64 living with HIV in the UK ranged from around 
24,000 in 2001 to 38,000 in 2009 with a rather constant number of 9,000 men who 
were unaware of their infection. These 1,093 parameter sets were later used for 
simulating the HIV epidemic in MSM in the UK from 2001 to 2020 and evaluating the 
contributions to HIV transmission of various biological and behavioural factors. 
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  (a)          (b)          (c) 
 
Figure 5-1: The model fitting of the number of MSM aged 15-64 living with HIV in the UK 
(a) Overall HIV prevalence, (b) Diagnosed HIV prevalence (not used for model fitting), (c) Undiagnosed HIV prevalence. The dashed lines showed ranges of the fitting data. Note 
that the upper limits of reported estimates were increased by 15% to compensate for difference of age range between the reported estimates and this study (15-59 vs. 15-64, 
respectively). The grey lines represent model estimates from all 20,000 sampled parameter sets. The green lines represent model estimates from 1,093 parameter sets that yielded 
both the overall and undiagnosed HIV prevalence within the range of the 2001–2009 fitting data, simultaneously. The yellow lines indicated median of the green-line estimates.
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5.3. Model validation 
The model and its parameters values were validated collectively by comparing the 
output estimates derived from 1,093 parameter sets to the time-series surveillance data 
and reported estimates that were not used for fitting the model, which were the annual 
number of new HIV infections, the number of new HIV diagnoses, and the number of 
MSM on antiretroviral treatment (ART). Figure 5-2 shows a comparison of new HIV 
infections. The model yields a total of 21,677 (15,505-29,596) new infections during 
2001–2009 with the annual numbers lie within the reported ranges [97] across the 
entire time period (Figure 5-2a). The upward trend of new infections during the early 
periods followed by a slight decline and levelling off can be observed from both the 
model and reported estimates. There were no reported estimates stratified by age 
groups. However, the smaller number of new infections of the older group (Figure 5-
2c) compared to the younger group (Figure 5-2b) were also consistent with the 2010 
data from the national monitoring system of recent HIV infections which suggesting 
much lesser proportions of recent infection in newly-diagnosed MSM aged 35 and 
over (7-23%) in contrast to those of aged less than 35 (24-41%) [54,70]. 
The median estimates of individuals in the ART stage at the end of the year during 
2001–2009 were compared with the observed numbers of MSM on ART obtained 
from the PHE SOPHID database (Figure 5-3). The upward trend in the numbers of 
ART-treated MSM was observed during the last decade (from around 9,200 in 2001 to 
21,300 in 2009) and the model estimates follow the trend consistently (from 10,952 in 
2001 to 23,865 in 2009). Note that the estimates from this study were somewhat 
higher than the observed data, particularly in the early phase, probably because it was 
assumed that once an individual is treated with ART he remains in the ART stage until 
being removed from the model, while in the actual situation a proportion of MSM may 
stop the treatment due to a number of reasons, e.g. poor adherence. 
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  (a)          (b)          (c) 
 
Figure 5-2: Comparison of annual numbers of new HIV infections between model and reported estimates for model validation 
(a) Overall new HIV infections, (b) new HIV infections in MSM aged 15-34, (c) new HIV infections in MSM aged 35-64. The dots and dashed lines indicated the reported 
estimates and 95% credible intervals of annual numbers of new HIV infections in MSM in England and Wales. The explanations of all other items in this figure are provided in the 
legends of Figure 5-1. 
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Figure 5-3: Comparison of the number of MSM on ART between model estimates 
and reported data for model validation 
The dots indicated the reported numbers of UK MSM on ART from 2001–2009. The explanations of all 
other items in this figure are provided in the legends of Figure 5-1. 
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The numbers of new diagnoses stratified by age groups are shown in Figure 5-4. The 
2001–2009 new diagnoses data in UK MSM aged 15-64 were obtained from PHE 
New diagnoses databases. Since the selected data matched exactly with the 
demographics of the modelled populations, I validated the HIV transmission model 
more quantitatively by calculating a simple goodness-of-fit indicator from percentage 
differences between observed data and model estimates for each available data points, 
1 100%t t
t
O E
O

  , where tO  and tE  are, respectively, the observed data and model 
estimates at time t. The combined value is an average of all individual data points‘ 
average goodness-of-fit. A larger value reflected a better consistency with the data. 
For the younger group, the goodness-of-fit value of the new diagnoses during 2001–
2009 was 93.9% when comparing using the median estimates. For MSM aged 35-64, 
the goodness-of-fit value was 88.6%. Overall, the predicted trends of new HIV 
diagnoses in this research were well consistent with the national surveillance data with 
the goodness-of-fit value of 91.2%. 
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  (a)         (b)         (c) 
 
Figure 5-4: Comparison of the number of new diagnoses between model estimates and reported data for model validation 
(a) Overall new HIV diagnoses, (b) new HIV diagnoses in MSM aged 15-34, (c) new HIV diagnoses in MSM aged 35-64. The dots indicated the reported new HIV diagnoses in 
UK MSM from 2001–2009. The explanations of all other items in this figure are provided in the legends of Figure 5-1. 
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The CD4-specifc new diagnoses data and the estimates are shown in Figure 5-5. Due 
to uncertainty associated with missing values of the reported data, I skipped the 
calculation of goodness-of-fit and visually inspected the consistency. The median 
estimates resembled quite closely both trend and magnitude of the new diagnoses data 
in all CD4 stages and both age groups. At the end of 2009, the estimation of the 
numbers of newly diagnosed MSM were 757, 571, 400, and 504 for CD4≥500, 350-
499, 200-349, and <200 cells/µL, respectively, which matched closely the 805, 535, 
426, and 440 cases of the reported data. 
In addition, the model estimated a total of 39,295 HIV-positive MSM aged 15-64 at 
the end of 2010 which was in line with the 2010 estimates of 40,100 (35,300-46,700) 
MSM aged 15-59 living with HIV in the UK [70]. At the same period of time, the 
model also approximated that 21% of HIV-positive MSM were unaware of their 
infection compared to the reported estimate of 26% (16-36%) [70]. 
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Figure 5-5: Comparison of the number of new diagnoses stratified by CD4 stages between model estimates and reported data for model validation 
Rows (a), (b), and (c): Overall new HIV diagnoses, new HIV diagnoses in MSM aged 15-34, and new HIV diagnoses in MSM aged 35-64, respectively. Columns (1), (2), (3), and 
(4): New HIV diagnoses at CD4  500, 350-499, 200-349, and <200 cells/µL, respectively. The dots indicated the reported new HIV diagnoses in UK MSM from 2001–2009. The 
explanations of all other items in this figure are provided in the legends of Figure 5-1. 
(a) 
 
 
 
 
 
 
 
(b) 
 
 
 
 
 
 
 
(c) 
(1)      (2)      (3)      (4) 
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5.4. Model programming 
The computational programming language R [100] is used for model construction and 
analysis in this study. Code processing time is also taken into consideration and was 
minimised as much as possible. Simple calculations and graphical outputs were carried 
out in both R and the spreadsheet application. 
 
Programming a complicated model usually involves hundred or even thousand lines of 
computer codes and mistakes, although known to exist, are often difficult to identify. 
Two verifying procedures were used to ensure code correctness. First, there are certain 
rules that should never be violated if the codes are to be working properly. For 
instance, the probability and proportion sum to one, and the count data could never be 
a negative value. These rules can be placed throughout the programme to help identify 
any mistakes as soon as possible. 
Another is that codes for solving differential equations were tested using the 
instructions suggested by Knupp and Salari [101]. Subsets of the R codes, particularly 
the complex ones, can be compared to the equivalent codes in other differential 
equation programmes, such as Berkeley Madonna [102]. Other types of code can be 
verified against manual calculation in a spreadsheet application. 
5.5. Publication 
The manuscript of the main findings on the current epidemic, entitled ‗Modelling the 
HIV epidemic among men who have sex with men in the United Kingdom: 
quantifying the contributions to HIV transmission to better inform prevention 
initiatives‘, including supplementary materials on model fitting and validation has 
been published in AIDS in January 2015 [61]. The main aims of the article are to 
estimate the levels of HIV incidence and prevalence up to the year 2020 and assess the 
contribution of various MSM subgroups to HIV transmission among MSM in the UK. 
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5.6. Supplementary results 
5.6.1. Epidemic projections 
5.6.1.1. MSM living with HIV 
The projections for the number of MSM living with HIV in the UK stratified by 
diagnosis status, age group, and sexual activity level are shown in Figure 2 in the main 
article. The model estimated that there would be 43,682 (35,833-56,387) MSM living 
with HIV by the end of 2013 corresponding to a prevalence rate of 6.3% (5.1-8.1%). 
By 2020, the estimated HIV prevalence rose to 52,268 (38,064-81,006) equivalent to 
7.3% (5.3-11.3%). During this period (2013–2020), the overall HIV prevalence 
increased at an average annual rate of 2.6% with the majority of men being diagnosed, 
particularly those aged 35-64. The numbers of undiagnosed individuals stabilised over 
time in all age groups. For both sexual activity groups, the overall HIV prevalence at 
the end of 2013 are similar, but the numbers of undiagnosed men in the high-activity 
group is roughly twice the number in the low-activity group (5,584 vs. 2,311). The 
number of diagnosed HIV infections is similar in both activity groups (low: 17,951, 
high: 17,376). 
5.6.1.2. New HIV infections 
According to the median estimates of new HIV infections in Figure 2 in the main 
article, our model indicated that there was an increase in the overall HIV incidence 
during 2001–2005 before a slight decline during 2005–2009 and levelling off at 
around 2,400 cases per year (incidence rate of 0.35%) after that, however this is 
associated with large uncertainty. The 2001–2020 cumulative numbers of new 
infections were estimated to be 48,148 (29,254-83,713). The rates of new infections in 
the younger group were about twice as many as those in the older group (0.49% vs. 
0.25% in 2013), while unsurprisingly, the incidence in the high-activity men was 
substantially higher than in the low-activity men (0.64% vs. 0.14% in 2013). 
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5.6.2. Population attributable fractions 
The population attributable fractions (PAFs) stratified by age groups and sexual 
activity levels are shown in Figure 5-6. The details of analysis and calculation of PAF 
are provided in the main text. 
The PAFs for all MSM are presented in Figure 5-6a. Figure 5-6b and Figure 5-6c 
show that eliminating HIV spread from MSM aged 15-34, while being highly 
beneficial within the age group (average PAF of 75%), would prevent a almost half of 
new infections in MSM aged 35-64 (average PAF of 46%) which is considerably high 
compared to only 61% in the case where there were no transmission from within the 
older group itself. Moreover, the contributions remained stable over the 20-year period 
which, taken together, indicated that interventions targeting young MSM could prove 
effective in tackling HIV infection. Other factors were shown to uniformly affect both 
age groups. 
The PAF calculated from the incidence rates stratified by sexual activity levels are 
shown in Figure 5-6d and Figure 5-6e. For both groups, the largest PAF is still 
associated with transmission from men at non-PHI stages while the contributions of 
men at PHI are among the lowest. The smallest PAF for the low-activity group is 5% 
on average for one-off sexual partnership due to low rates of acquiring new partners 
(≤1 per year) of men in this group (Figure 5-6d). The treated men seem to contribute 
considerably low (average PAF of 14%) to HIV infections in high-activity group as a 
result of small proportions of men who still performed high activity after HIV 
diagnosis (Figure 5-6e). This also explains why the low-activity PAF of HIV diagnosis 
and treatment changed more rapidly over time than that of high-activity men. The 
analyses also indicate that HIV-positive men in high-activity group accounted for 
more infections in low-activity populations than do the low-activity men (Figure 5-6d 
and Figure 5-6e), which is similar to how young MSM contributed to new infections 
in both age groups (Figure 5-6b and Figure 5-6c). 
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Moreover, the repeat sexual partnerships of high-activity MSM make a small 
contribution to new infections in low-activity men (Figure 5-6d), whereas the repeat 
sexual partnerships of low-activity MSM make almost no contribution to HIV 
infection in high-activity men (Figure 5-6e), demonstrating the minor impact of HIV 
transmission between the two sexual activity groups. 
5.6.3. Sensitivity analysis 
The sensitivity of model predictions was assessed using the regression trees technique 
[103]. We selected total new HIV infections during 2001–2020 as the response 
variable and all filtered parameters except the model initial conditions as the predictor 
variables (Table S14). We grew the tree and pruned it by selecting the tree size that 
minimised the sum of squared errors [103]. 
The sensitivity analysis regression tree a total of 7 splits, 8 terminal nodes, and 4 
model parameters (Figure 5-7). The most influential model parameter for the new 
infections during 2001–2020 based on the number of appearances and its level in the 
tree was the per-URAI act transmission probability in non-PHI stages. The incidence 
estimates were also highly sensitive to the per-UIAI act non-PHI transmission 
probability, condom efficacy, and the frequency of sex acts with a repeat sexual 
partner. 
The uncertainty of the estimated infections (43,560-64,980) indicated the importance 
of these factors in the epidemic of HIV in UK MSM. The number of new infection 
over 2001–2020 could be as high as 64,980 if the mean infectivity of an URAI and 
UIAI act at non-PHI stages was greater than 2.0% and 1.0%, respectively. Conversely, 
if several conditions represented by the route on the far left of the tree (Figure 5-7) 
were met simultaneously, the incidence of HIV could have been as low as 43,560, 
corresponding to 13% reduction from the mean estimates of 50,110 cases in the 
baseline scenario (root node). 
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(a) All MSM 
 
(b) MSM aged 15-34 
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(c) MSM aged 35-64 
 
(d) Low-activity MSM 
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(e) High-activity MSM 
 
Figure 5-6: Population attributable fractions of various factors for HIV incidence among MSM in the UK stratified by age groups and sexual 
activity levels 
PAF: Population attributable fractions; PHI: Primary HIV infection. The figure shows the impacts of removing the corresponding factors from all MSM on the incidence of HIV in 
(a) all MSM, (b) MSM aged 15-34, (c) MSM aged 35-64, (d) low-activity MSM, and (e) high-activity MSM. The green, blue, and purple bars represent 2001–2002, 2014–2015, 
and 2019–2020 PAF respectively. The error bars show the ranges between 2.5th and 97.5th percentiles of the estimated PAF. 
 
 
 
 
 
  
Narat Punyacharoensin            Chapter 5: Current HIV Epidemic 
139 
 
 
 
Figure 5-7: Model regression tree for sensitivity analysis 
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5.7. Conclusion 
Chapter 5 has presented the findings on the contributions made by various HIV-
positive subpopulations to HIV transmission among UK MSM. The majority of new 
HIV infections during 2001–2020 is expected to be accounted for by a small group of 
highly sexually active individuals under the age of 35 years, living with undiagnosed 
HIV in the asymptomatic stage. In the next chapter, a range of interventions will be 
investigated for the potential impact in preventing HIV transmission from sex between 
men in the UK. 
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6.1. Introduction 
The main aim of this chapter is to assess the potential impact of a range of 
interventions to help inform effective HIV control strategies in the future. The HIV 
epidemic in men who have sex with men (MSM) in the UK with effects of HIV 
prevention interventions will be projected up to 2020. The primary research questions 
3 and 4 will be addressed in this chapter. 
6.2. Publication 
The manuscript on the potential impact of HIV prevention interventions, entitled 
‗Potential impact of pre-exposure prophylaxis and combination HIV prevention for 
men who have sex with men in the United Kingdom: a mathematical modelling study‘, 
has been submitted to The Lancet HIV. The details on model modifications to 
incorporate interventions have also been submitted as supplementary materials. Both 
the main text and supplementary materials of this article are presented in this chapter 
in the submitted format. 
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6.3. Conclusion 
The previously developed HIV transmission model was modified and used to 
investigate the potential effects of HIV prevention interventions in reducing HIV 
transmission among MSM in the UK. Up until now, all four primary research 
questions have been addressed and more insights into HIV epidemic in UK MSM have 
been provided. The final chapter will draw important conclusions from the findings of 
this study and discuss about its main limitations and future improvements.  
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7.1. Summary of findings 
The aim of this research was to provide insight into the contributions of various 
subpopulations to HIV transmission among men who have sex with men (MSM) in the 
UK, and evaluate potential effectiveness of a variety of interventions to prevent 
onward transmission in these populations. The partnership-based mathematical model 
for HIV transmission and control that has been rigorously calibrated to match the HIV 
epidemic in UK MSM was used for addressing the aims of the study. Several 
important issues identified by the review of the literature were taken into account in 
this study including the lack of recent modelling works on HIV transmission among 
UK MSM, the lack of studies that used more realistic modelling approaches, and the 
lack of properly fitted and validated modelling studies. 
The model estimated that there were around 44,000 MSM living with HIV in 2013 
and, without additional interventions, this number could reach 52,000 by the end of 
2020. The number of new HIV infections was estimated at approximately 2,400 cases 
each year until the end of the decade. The analyses of factor contributions showed that 
the current epidemic of HIV in UK MSM is sustained primarily by high-activity MSM 
aged below 35 years, living with undiagnosed HIV in asymptomatic disease stages. 
The contributions of primary stage (PHI) to new HIV infections among UK MSM 
were estimated to be small, which is probably due to the relatively short duration of 
this high infectiousness stage compared to all other subsequent stages. The regression 
tree analysis confirmed that non-primary HIV infection stages were the most 
important drivers of the epidemic, while PHI-related parameters were not among 
them. The findings also suggested that the majority of new infections occurred within 
a repeat sexual partnership which highlighted an important role of long-term 
relationships in transmitting HIV. 
The analysis on potential impacts of HIV prevention interventions illustrated that pre-
exposure prophylaxis (PrEP) could prevent the largest number of infections among all 
other programs when implemented individually, whereas reducing the number of one-
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off sexual partners was shown to be the least effective strategy. Increasing HIV testing 
frequency could save thousands of MSM from HIV, and substantially more if the test-
and-treat program is also implemented. A large number of HIV infections could also 
be averted by counselling programs that aim at sexual behavioural changes, i.e. 
reducing the number of repeat sexual partners and unsafe sex with repeat sexual 
partners, but these programs may be difficult to put into practice. 
In a more practical scenario where only relatively small coverage of interventions was 
achieved, simultaneously offering PrEP, expanding HIV testing, and initiating a test-
and-treat program had great potential to become a successful combination. Although 
risk compensation could adversely affect the overall effectiveness, it is unlikely to 
completely negate the benefit of the interventions. However, infection eradication was 
shown not to be realistic over this time frame even after a successful implementation 
of the most effective combined interventions. 
7.2. Strengths 
There were a number of the key strengths to this research. First, the partnership-based 
modelling approach used in this study provided more realistic representation of sexual 
partnership formation and termination and allowed finite duration of partnerships 
which resulted in more accurate research outcomes than the non-partnership-based 
modelling approach. 
Second, based on the review in Chapter 2, the HIV transmission model developed and 
used here was among the most complex MSM models in the literature that 
incorporated a large number of heterogeneities, including age group, sexual activity 
level, sexual partner type, partnership status, CD4 stages, diagnosis status, and 
antiretroviral treatment (ART) status. This allowed the effects of various behavioural 
and biological factors to be taken into account simultaneously and provided better 
estimations of HIV transmission and control. 
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Third, model parameterisation was rigorously carried out using available data from 
various sources including behavioural surveys, national surveillance databases, and 
findings from systematic reviews and meta-analysis studies. The model were then 
fitted to multiple time-series estimates and validated against the datasets that were not 
used in the model fitting to ensure that the underlying computations in the model 
resembled closely to the epidemic of HIV among UK MSM. 
Finally, the simulation approach adopted here provided a large number of plausible 
outcomes which allowed uncertainty around the results to be explicitly extracted and 
investigated. Therefore, all key model outputs in this study were presented with the 
uncertainty range which was consistent with the recommended principles for good 
HIV epidemiology modelling [104]. 
7.3. Limitations 
The main limitation of this study concerned issues with the available data used for 
model parameterisation. First, the lack of required data from behavioural surveys 
prevented incorporating some important heterogeneities into the model. For example, 
the partnership types could be stratified into steady partner and causal partner instead 
of repeat sexual partner and one-off sexual partner as carried out in this study. 
However, the behavioural data stratified by steady and causal partners, e.g. the number 
of partners, the frequency of sexual acts, and the duration of relationships, were not 
available by the time this study was undertaken. Therefore, such stratification of 
partnership types could not be completed. Second, the completeness and 
representativeness issue of the data from behavioural surveys, which are among the 
main sources of uncertainty around all behavioural parameters in the model. For 
example, NATSAL of the year 2000 was a national-based probability-sampling survey 
of sexual behaviours that were representative of the UK population. The age range of 
the surveyed populations of 16-44 years was, however, not compatible with the 15-64 
age range in this research. The survey also included only a small number of MSM 
which made further stratifications not possible. In contrast, GMSHS and GYM studies 
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were community-based convenience-sampling surveys in London which, without a 
prior adjustment, would not be suitable for representing MSM populations at the 
national level. The sample size and age range were, however, sufficiently large for in-
depth analyses undertaken throughout this study. 
MSM stratification in this study were also limited to only two age groups and two 
sexual activity levels which may not be sufficiently granulated to capture hidden or 
unknown heterogeneities that could be important in determining the spread of HIV. 
This is partly because of the small sample size of MSM in behavioural surveys 
mentioned earlier, and also because of extra computational burdens that further MSM 
stratification would add to the model. There were already a total of 1,980 model 
equations in the PrEP model (Chapter 6) which is considered extremely large in 
comparison to most HIV transmission models in other studies. Adding a few more 
subgroups would exponentially increase the number of model equations and time to 
complete the simulations which was not viable under the time constraint of this study. 
Many assumptions made in this study were by necessity a simplification of the real-
world situations and may not actually occur. For example, the epidemic projection was 
based on the assumption that there were no effects of additional interventions and all 
model parameters remained constant until the end of projection. This may be true only 
for the near future but unlikely for the long term. However, such projection was meant 
to provide an indication of the epidemic without additional intervention to emphasise 
the need of additional HIV prevention efforts rather than to precisely project its future 
course. 
The effects of ART resistance and co-infection with other sexually transmitted 
diseases on HIV transmission were not explicitly included in this research. However, 
the model parameters were fitted to the current HIV epidemic among UK MSM and 
have therefore already taken these factors into account. Unless the prevalence of co-
infection and drug resistance strain changes greatly during the intervention period, 
their effects on the model outputs may be modest. 
Narat Punyacharoensin  Chapter 7: Discussion and Conclusion 
241 
 
7.4. Implication for HIV prevention policy 
This research suggests that the current epidemic of HIV among MSM in the UK is 
driven mainly by undiagnosed HIV-positive MSM in the asymptomatic stage aged 
below 35 years who have high sexual activity levels. Any successful efforts to reduce 
the number of this high-risk group are likely be an effective HIV control strategy. 
Reducing the number of sexual partners was shown to be effective against HIV 
transmission but may be difficult to put into practice. Expanding HIV testing, on the 
other hand, should be more practical. Offering HIV testing beyond STI clinics, e.g. in 
routine health checks or when MSM present with other health problems, may help 
increase HIV testing uptake and provide necessary counselling for HIV-positive men. 
Encouraging more HIV testing is also crucial in determining the success of subsequent 
programs including test-and-treat. This study shows that a test-and-treat program, 
when implemented without a program to increase HIV testing uptake, has a limited 
impact against HIV transmission at the population level. With both programs 
combined, not only the prevention effectiveness increases substantially, but the 
benefits are also gained from a number of key strengths offered by this combination. 
The provision of PrEP could save thousands of lives from HIV within a few years 
after the introduction. Initiating PrEP would also increase the proportion of diagnosed 
individuals since it requires HIV testing prior and during treatment administration. 
However, the main concern lies in the effects of risk compensation that could negate 
the prevention benefits. It is, thus, important to keep monitoring the level of risk 
behaviours in PrEP users and continue the research to better understand risk-taking 
behaviour and PrEP application. 
In conclusion, it is clear that, in populations most severely affected by the HIV 
epidemic such as MSM, a combination of interventions is necessary to bring the 
epidemic under control. Expanding HIV testing remains the core of the HIV 
prevention strategy among MSM in the UK. Simultaneously implemented with the 
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programs to offer immediate ART, and PREP is likely to marked improve the overall 
effectiveness against HIV transmission and become the key preventive measures for 
HIV/AIDS in the UK. 
7.5. Future improvements 
This PhD study highlights a need for further research in several aspects surrounding 
the modelling of HIV transmission including model structure, parameterisation, data, 
and analysis. 
The use of partnership-based model in this study provided more realistic approach to 
modelling HIV transmission between sexual partners. However, the number of model 
equations increases exponentially with the number of subgroups, e.g. age groups, 
sexual activity levels, and disease stages, and rapidly becomes a computational 
burden. A method to simplify the modelling process and reduces the number of 
equations without sacrificing the partnership formation mechanism of the model will 
thus be very helpful for further application of the model. Such simplification may be 
achievable by approximating the probability that paired individuals select their 
partners from each subgroup and calculate the probability of HIV transmission within 
these partnerships without actually pairing them as done in the original partnership-
based approach. This process would then be repeated every modelling time step 
allowing for changes over time in the size of subgroups, while other model 
computations remain unaffected. The successful implementation of this approach will 
greatly reduce the number of model equations, for instance, in Chapter 5 from 1,296 to 
as small as 120, which will make room for other important heterogeneities to be 
incorporated into the model, such as STI co-infection, ART resistance, and 
recreational drug use that has recently been found to have a strong association with 
unprotected sex among UK MSM [105]. 
As for model parameterisation, an increasing number of studies have applied a variety 
of Bayesian approach to parameter estimation in the context of modelling HIV 
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transmission and other infectious diseases. The key advantage is that the approach can 
utilise information from multiple sources to simultaneously estimate a number of 
parameters and incorporates uncertainty analyses in the fitting process [104,106]. For 
example, a Bayesian melding approach combines beliefs, information, and data on 
inputs and output of the model using a simulation technique to estimate the model 
parameters with uncertainty ranges [107]. The approach has recently been used to fit 
the heterosexual HIV transmission model to HIV prevalence data in Malawi [58], as 
well as fitting the influenza transmission model to incidence data in Belgium, the 
Netherlands, and Portugal [108]. Another method under the Bayesian framework 
called the evidence synthesis has been applied for modelling HIV transmission among 
MSM in England and Wales to simultaneously estimate various model parameters 
using information on demographics, sexual behaviours, and sexual contacts [54]. To 
date, these Bayesian methods have never adopted for parameterising a partnership-
based HIV transmission model, and it is thus useful to explore if such approaches can 
provide more accurate estimates over other methods currently used. 
Regarding to the data issues, increasing the availability of more accurate and 
granulated data is always welcome. The findings from Chapter 5 that showed a clear 
difference in the level of contribution between repeat and one-off sexual relationships 
suggested that the future sexual behavioural studies may need to focus on 
distinguishing between different types of partnerships, e.g. steady and casual, in a 
more precise manner. Although this PhD study showed that there is a good possibility 
that steady partnerships also play an important role in driving the UK epidemic, a 
further study is needed to confirm this finding. If accurate information on the average 
number of partners, the frequency of sexual acts, the partnership duration, and the 
partnership concurrency, are made available for each type of partnership, then the 
model can be reparameterised to assess various aspects of partnership types and help 
clarify whether HIV transmission within steady or casual partnerships is the main 
contributor for the ongoing epidemic. 
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The model-based estimates would also benefit from more accurate data on how UK 
MSM select their sexual partners based on age, sexual activity, and HIV infection 
status, as well as other important characteristics that influence the incidence of HIV 
such as ethnicity and geographic area [109]. This should help with constructing a more 
precise sexual mixing matrix which may reveal some important patterns in 
subpopulations. Also, the future research will benefit from the updated information on 
sexual behaviours and attitudes in UK MSM provided by the next round of the 
NATSAL survey conducted in 2010–2012 [63]. The survey reports on same-sex 
activity and expands the sample‘s age range to 16-74 years which will help resolve 
this uncertainty and lead to more precise estimates. 
The estimates of HIV transmission probability, which was showed in Chapter 5 to be 
among the most influential parameters in the model, require an update as new 
evidence becomes available in the future. An empirical study designed to estimate per-
act HIV transmission probability among MSM in the UK or other developed countries 
where ART is widely accessible would be of great importance for improving the 
accuracy of transmission rates. If ART with a good adherence could substantially 
suppress HIV transmission through unprotected sex among seroconcordant couples 
[110], it is highly possible that the future contribution of ART-treated men to new HIV 
infections will be much less than that estimated in this study. 
Finally, including cost-effectiveness analysis for HIV prevention interventions will 
substantially improve the usefulness of this study. It is possible that any highly 
effective programmes against HIV transmission suggested here may not be cost-
effective in the actual UK setting. Therefore, further economic evaluations are 
necessary to inform timely and accurate public health decision making. The 
comprehensiveness of the model also supports further expansion to HIV epidemics in 
other populations and locations. Depending on the available data, the model could be 
easily modified to assess the impact of any specific HIV prevention interventions in 
greater detail. Its flexible structure also allows the future incorporation into the model 
of other alternative interventions in parallel with those already included in this PhD. 
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7.6. Final words 
This study provided a better overall understanding of the dynamics of the HIV 
epidemic among MSM in the UK. The development of partnership-based model was 
expected to emphasise the importance of partnership characteristics in modelling HIV 
transmission and control. A number of integrated heterogeneities and better use of 
available data allowed this study to make the most of available knowledge and 
information that exist in the context of HIV epidemics. The achievement of this study 
will encourage a greater use of an alternative model and soon it may become one of 
the standard HIV modelling approaches. The findings from an application to the HIV 
epidemic in MSM should help inform HIV prevention and control strategies in the 
UK, which will ultimately bring a benefit to the society as a whole. 
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